id	sid	tid	token	lemma	pos
dpc-865	1	1	dermatology	dermatology	NOUN
dpc-865	1	2	:	:	PUNCT
dpc-865	1	3	practical	practical	ADJ
dpc-865	1	4	and	and	CCONJ
dpc-865	1	5	conceptual	conceptual	ADJ
dpc-865	1	6	observation	observation	NOUN
dpc-865	2	1	|	|	ADV
dpc-865	2	2	dermatol	dermatol	NOUN
dpc-865	2	3	pract	pract	PROPN
dpc-865	2	4	concept	concept	NOUN
dpc-865	2	5	2015;5(1):18	2015;5(1):18	NUM
dpc-865	2	6	91	91	NUM
dpc-865	2	7	dermatology	dermatology	NOUN
dpc-865	2	8	practical	practical	ADJ
dpc-865	2	9	&	&	CCONJ
dpc-865	2	10	conceptual	conceptual	ADJ
dpc-865	2	11	www.derm101.com	www.derm101.com	NUM
dpc-865	2	12	case	case	NOUN
dpc-865	2	13	report	report	VERB
dpc-865	2	14	a	a	DET
dpc-865	2	15	full	full	ADJ
dpc-865	2	16	-	-	PUNCT
dpc-865	2	17	term	term	NOUN
dpc-865	2	18	male	male	ADJ
dpc-865	2	19	newborn	newborn	NOUN
dpc-865	2	20	was	be	AUX
dpc-865	2	21	admitted	admit	VERB
dpc-865	2	22	to	to	ADP
dpc-865	2	23	our	our	PRON
dpc-865	2	24	hospital	hospital	NOUN
dpc-865	2	25	with	with	ADP
dpc-865	2	26	diagnosis	diagnosis	NOUN
dpc-865	2	27	of	of	ADP
dpc-865	2	28	right	right	ADJ
dpc-865	2	29	latero	latero	NOUN
dpc-865	2	30	-	-	PUNCT
dpc-865	2	31	cervical	cervical	ADJ
dpc-865	2	32	vascular	vascular	ADJ
dpc-865	2	33	mass	mass	NOUN
dpc-865	2	34	present	present	ADJ
dpc-865	2	35	at	at	ADP
dpc-865	2	36	birth	birth	NOUN
dpc-865	2	37	(	(	PUNCT
dpc-865	2	38	figure	figure	NOUN
dpc-865	2	39	1	1	NUM
dpc-865	2	40	)	)	PUNCT
dpc-865	2	41	.	.	PUNCT
dpc-865	3	1	he	he	PRON
dpc-865	3	2	was	be	AUX
dpc-865	3	3	transferred	transfer	VERB
dpc-865	3	4	to	to	ADP
dpc-865	3	5	our	our	PRON
dpc-865	3	6	center	center	NOUN
dpc-865	3	7	one	one	NUM
dpc-865	3	8	week	week	NOUN
dpc-865	3	9	after	after	ADP
dpc-865	3	10	his	his	PRON
dpc-865	3	11	birth	birth	NOUN
dpc-865	3	12	due	due	ADP
dpc-865	3	13	to	to	ADP
dpc-865	3	14	a	a	DET
dpc-865	3	15	progressive	progressive	ADJ
dpc-865	3	16	increase	increase	NOUN
dpc-865	3	17	of	of	ADP
dpc-865	3	18	tumor	tumor	NOUN
dpc-865	3	19	size	size	NOUN
dpc-865	3	20	.	.	PUNCT
dpc-865	4	1	no	no	DET
dpc-865	4	2	prior	prior	ADJ
dpc-865	4	3	therapy	therapy	NOUN
dpc-865	4	4	was	be	AUX
dpc-865	4	5	given	give	VERB
dpc-865	4	6	.	.	PUNCT
dpc-865	5	1	physical	physical	ADJ
dpc-865	5	2	exam	exam	NOUN
dpc-865	5	3	revealed	reveal	VERB
dpc-865	5	4	a	a	DET
dpc-865	5	5	12x10	12x10	NUM
dpc-865	5	6	cm	cm	NOUN
dpc-865	5	7	mixed	mixed	ADJ
dpc-865	5	8	(	(	PUNCT
dpc-865	5	9	deep	deep	ADJ
dpc-865	5	10	and	and	CCONJ
dpc-865	5	11	superficial	superficial	ADJ
dpc-865	5	12	)	)	PUNCT
dpc-865	5	13	plaque	plaque	NOUN
dpc-865	5	14	-	-	PUNCT
dpc-865	5	15	like	like	ADJ
dpc-865	5	16	lesion	lesion	NOUN
dpc-865	5	17	with	with	ADP
dpc-865	5	18	ecchymosis	ecchymosis	NOUN
dpc-865	5	19	.	.	PUNCT
dpc-865	6	1	a	a	DET
dpc-865	6	2	severe	severe	ADJ
dpc-865	6	3	coagulopathy	coagulopathy	ADJ
dpc-865	6	4	with	with	ADP
dpc-865	6	5	profound	profound	ADJ
dpc-865	6	6	thrombocytopenia	thrombocytopenia	NOUN
dpc-865	6	7	(	(	PUNCT
dpc-865	6	8	27,000x109	27,000x109	NUM
dpc-865	6	9	/	/	SYM
dpc-865	6	10	l	l	NOUN
dpc-865	6	11	)	)	PUNCT
dpc-865	6	12	and	and	CCONJ
dpc-865	6	13	elevated	elevate	VERB
dpc-865	6	14	d	d	ADJ
dpc-865	6	15	-	-	PUNCT
dpc-865	6	16	dimer	dimer	ADJ
dpc-865	6	17	level	level	NOUN
dpc-865	6	18	(	(	PUNCT
dpc-865	6	19	84,369	84,369	NUM
dpc-865	6	20	mcg	mcg	PROPN
dpc-865	6	21	/	/	SYM
dpc-865	6	22	l	l	NOUN
dpc-865	6	23	)	)	PUNCT
dpc-865	6	24	were	be	AUX
dpc-865	6	25	observed	observe	VERB
dpc-865	6	26	,	,	PUNCT
dpc-865	6	27	all	all	PRON
dpc-865	6	28	of	of	ADP
dpc-865	6	29	which	which	PRON
dpc-865	6	30	supported	support	VERB
dpc-865	6	31	the	the	DET
dpc-865	6	32	diagnosis	diagnosis	NOUN
dpc-865	6	33	of	of	ADP
dpc-865	6	34	kasabach	kasabach	NOUN
dpc-865	6	35	-	-	PUNCT
dpc-865	6	36	merritt	merritt	PROPN
dpc-865	6	37	phenomenon	phenomenon	NOUN
dpc-865	6	38	(	(	PUNCT
dpc-865	6	39	kmp	kmp	PROPN
dpc-865	6	40	)	)	PUNCT
dpc-865	6	41	.	.	PUNCT
dpc-865	7	1	a	a	DET
dpc-865	7	2	doppler	doppler	NOUN
dpc-865	7	3	ultrasound	ultrasound	NOUN
dpc-865	7	4	study	study	NOUN
dpc-865	7	5	and	and	CCONJ
dpc-865	7	6	magnetic	magnetic	ADJ
dpc-865	7	7	resonance	resonance	NOUN
dpc-865	7	8	imaging	imaging	NOUN
dpc-865	7	9	(	(	PUNCT
dpc-865	7	10	mri	mri	NOUN
dpc-865	7	11	)	)	PUNCT
dpc-865	7	12	revealed	reveal	VERB
dpc-865	7	13	the	the	DET
dpc-865	7	14	importance	importance	NOUN
dpc-865	7	15	of	of	ADP
dpc-865	7	16	early	early	ADJ
dpc-865	7	17	diagnosis	diagnosis	NOUN
dpc-865	7	18	and	and	CCONJ
dpc-865	7	19	treatment	treatment	NOUN
dpc-865	7	20	of	of	ADP
dpc-865	7	21	kaposiform	kaposiform	NOUN
dpc-865	7	22	hemangioendothelioma	hemangioendothelioma	ADV
dpc-865	7	23	complicated	complicate	VERB
dpc-865	7	24	by	by	ADP
dpc-865	7	25	kasabach	kasabach	PROPN
dpc-865	7	26	-	-	PUNCT
dpc-865	7	27	merritt	merritt	PROPN
dpc-865	7	28	phenomenon	phenomenon	NOUN
dpc-865	7	29	grecia	grecia	PROPN
dpc-865	7	30	v.	v.	ADP
dpc-865	7	31	vivas	viva	NOUN
dpc-865	7	32	-	-	NOUN
dpc-865	7	33	colmenares	colmenare	NOUN
dpc-865	7	34	1	1	NUM
dpc-865	7	35	,	,	PUNCT
dpc-865	7	36	gema	gema	NOUN
dpc-865	7	37	l.	l.	PROPN
dpc-865	7	38	ramirez	ramirez	PROPN
dpc-865	7	39	-	-	PUNCT
dpc-865	7	40	villar2	villar2	PROPN
dpc-865	7	41	,	,	PUNCT
dpc-865	7	42	jose	jose	PROPN
dpc-865	7	43	bernabeu	bernabeu	PROPN
dpc-865	7	44	-	-	PUNCT
dpc-865	7	45	wittel3	wittel3	PROPN
dpc-865	7	46	,	,	PUNCT
dpc-865	7	47	jose	jose	PROPN
dpc-865	7	48	a.	a.	NOUN
dpc-865	7	49	matute	matute	PROPN
dpc-865	7	50	de	de	X
dpc-865	7	51	cardenas1	cardenas1	PROPN
dpc-865	7	52	,	,	PUNCT
dpc-865	7	53	israel	israel	PROPN
dpc-865	7	54	fernandez	fernandez	PROPN
dpc-865	7	55	-	-	PUNCT
dpc-865	7	56	pineda1	pineda1	NOUN
dpc-865	7	57	1	1	NUM
dpc-865	7	58	department	department	NOUN
dpc-865	7	59	of	of	ADP
dpc-865	7	60	pediatric	pediatric	ADJ
dpc-865	7	61	surgery	surgery	NOUN
dpc-865	7	62	,	,	PUNCT
dpc-865	7	63	virgen	virgen	PROPN
dpc-865	7	64	del	del	PROPN
dpc-865	7	65	rocio	rocio	PROPN
dpc-865	7	66	children	children	PROPN
dpc-865	7	67	’s	’s	PART
dpc-865	7	68	hospital	hospital	NOUN
dpc-865	7	69	,	,	PUNCT
dpc-865	7	70	sevilla	sevilla	PROPN
dpc-865	7	71	,	,	PUNCT
dpc-865	7	72	spain	spain	PROPN
dpc-865	7	73	2	2	NUM
dpc-865	7	74	department	department	NOUN
dpc-865	7	75	of	of	ADP
dpc-865	7	76	pediatric	pediatric	ADJ
dpc-865	7	77	oncology	oncology	NOUN
dpc-865	7	78	,	,	PUNCT
dpc-865	7	79	virgen	virgen	PROPN
dpc-865	7	80	del	del	PROPN
dpc-865	7	81	rocio	rocio	PROPN
dpc-865	7	82	children	children	PROPN
dpc-865	7	83	’s	’s	PART
dpc-865	7	84	hospital	hospital	NOUN
dpc-865	7	85	,	,	PUNCT
dpc-865	7	86	sevilla	sevilla	PROPN
dpc-865	7	87	,	,	PUNCT
dpc-865	7	88	spain	spain	PROPN
dpc-865	7	89	3	3	NUM
dpc-865	7	90	department	department	PROPN
dpc-865	7	91	of	of	ADP
dpc-865	7	92	pediatric	pediatric	ADJ
dpc-865	7	93	dermatology	dermatology	NOUN
dpc-865	7	94	,	,	PUNCT
dpc-865	7	95	virgen	virgen	PROPN
dpc-865	7	96	del	del	PROPN
dpc-865	7	97	rocio	rocio	PROPN
dpc-865	7	98	children	children	PROPN
dpc-865	7	99	’s	’s	PART
dpc-865	7	100	hospital	hospital	NOUN
dpc-865	7	101	,	,	PUNCT
dpc-865	7	102	sevilla	sevilla	PROPN
dpc-865	7	103	,	,	PUNCT
dpc-865	7	104	spain	spain	PROPN
dpc-865	7	105	key	key	ADJ
dpc-865	7	106	words	word	NOUN
dpc-865	7	107	:	:	PUNCT
dpc-865	7	108	kaposiform	kaposiform	NOUN
dpc-865	7	109	hemangioendothelioma	hemangioendothelioma	NOUN
dpc-865	7	110	,	,	PUNCT
dpc-865	7	111	kasabach	kasabach	NOUN
dpc-865	7	112	-	-	PUNCT
dpc-865	7	113	merritt	merritt	PROPN
dpc-865	7	114	phenomenon	phenomenon	NOUN
dpc-865	7	115	,	,	PUNCT
dpc-865	7	116	vincristine	vincristine	NOUN
dpc-865	7	117	,	,	PUNCT
dpc-865	7	118	ticlopidine	ticlopidine	NOUN
dpc-865	7	119	,	,	PUNCT
dpc-865	7	120	aspirin	aspirin	NOUN
dpc-865	7	121	citation	citation	NOUN
dpc-865	7	122	:	:	PUNCT
dpc-865	8	1	vivas	viva	NOUN
dpc-865	8	2	-	-	NOUN
dpc-865	8	3	colmenares	colmenare	NOUN
dpc-865	8	4	gv	gv	ADP
dpc-865	8	5	,	,	PUNCT
dpc-865	8	6	ramirez	ramirez	PROPN
dpc-865	8	7	-	-	PUNCT
dpc-865	8	8	villar	villar	PROPN
dpc-865	8	9	gl	gl	PROPN
dpc-865	8	10	,	,	PUNCT
dpc-865	8	11	bernabeu	bernabeu	NOUN
dpc-865	8	12	-	-	PUNCT
dpc-865	8	13	wittel	wittel	PROPN
dpc-865	8	14	j	j	PROPN
dpc-865	8	15	,	,	PUNCT
dpc-865	8	16	matute	matute	PROPN
dpc-865	8	17	de	de	PROPN
dpc-865	8	18	cardenas	cardenas	PROPN
dpc-865	8	19	ja	ja	PROPN
dpc-865	8	20	,	,	PUNCT
dpc-865	8	21	fernandez	fernandez	PROPN
dpc-865	8	22	-	-	PUNCT
dpc-865	8	23	pineda	pineda	PROPN
dpc-865	8	24	i.	i.	PROPN
dpc-865	8	25	the	the	DET
dpc-865	8	26	importance	importance	NOUN
dpc-865	8	27	of	of	ADP
dpc-865	8	28	early	early	ADJ
dpc-865	8	29	diagnosis	diagnosis	NOUN
dpc-865	8	30	and	and	CCONJ
dpc-865	8	31	treatment	treatment	NOUN
dpc-865	8	32	of	of	ADP
dpc-865	8	33	kaposiform	kaposiform	NOUN
dpc-865	8	34	hemangioendothelioma	hemangioendothelioma	ADV
dpc-865	8	35	complicated	complicate	VERB
dpc-865	8	36	by	by	ADP
dpc-865	8	37	kasabach	kasabach	PROPN
dpc-865	8	38	-	-	PUNCT
dpc-865	8	39	merritt	merritt	PROPN
dpc-865	8	40	phenomenon	phenomenon	NOUN
dpc-865	8	41	.	.	PUNCT
dpc-865	9	1	dermatol	dermatol	NOUN
dpc-865	9	2	pract	pract	PROPN
dpc-865	9	3	concept	concept	NOUN
dpc-865	9	4	2015;5(1):18	2015;5(1):18	NUM
dpc-865	9	5	.	.	PUNCT
dpc-865	9	6	doi	doi	NOUN
dpc-865	9	7	:	:	PUNCT
dpc-865	9	8	10.5826	10.5826	NUM
dpc-865	9	9	/	/	SYM
dpc-865	9	10	dpc.050118	dpc.050118	PROPN
dpc-865	9	11	received	receive	VERB
dpc-865	9	12	:	:	PUNCT
dpc-865	9	13	august	august	PROPN
dpc-865	9	14	19	19	NUM
dpc-865	9	15	,	,	PUNCT
dpc-865	9	16	2014	2014	NUM
dpc-865	9	17	;	;	PUNCT
dpc-865	9	18	accepted	accept	VERB
dpc-865	9	19	:	:	PUNCT
dpc-865	9	20	september	september	PROPN
dpc-865	9	21	22	22	NUM
dpc-865	9	22	,	,	PUNCT
dpc-865	9	23	2014	2014	NUM
dpc-865	9	24	;	;	PUNCT
dpc-865	9	25	published	publish	VERB
dpc-865	9	26	:	:	PUNCT
dpc-865	9	27	january	january	PROPN
dpc-865	9	28	30	30	NUM
dpc-865	9	29	,	,	PUNCT
dpc-865	9	30	2015	2015	NUM
dpc-865	9	31	copyright	copyright	NOUN
dpc-865	9	32	:	:	PUNCT
dpc-865	9	33	©	©	PROPN
dpc-865	9	34	2015	2015	NUM
dpc-865	9	35	vivas	viva	NOUN
dpc-865	9	36	-	-	NOUN
dpc-865	9	37	colmenares	colmenare	NOUN
dpc-865	9	38	et	et	NOUN
dpc-865	9	39	al	al	PROPN
dpc-865	9	40	.	.	PUNCT
dpc-865	10	1	this	this	PRON
dpc-865	10	2	is	be	AUX
dpc-865	10	3	an	an	DET
dpc-865	10	4	open	open	ADJ
dpc-865	10	5	-	-	PUNCT
dpc-865	10	6	access	access	NOUN
dpc-865	10	7	article	article	NOUN
dpc-865	10	8	distributed	distribute	VERB
dpc-865	10	9	under	under	ADP
dpc-865	10	10	the	the	DET
dpc-865	10	11	terms	term	NOUN
dpc-865	10	12	of	of	ADP
dpc-865	10	13	the	the	DET
dpc-865	10	14	creative	creative	ADJ
dpc-865	10	15	commons	common	NOUN
dpc-865	10	16	attribution	attribution	NOUN
dpc-865	10	17	license	license	NOUN
dpc-865	10	18	,	,	PUNCT
dpc-865	10	19	which	which	PRON
dpc-865	10	20	permits	permit	VERB
dpc-865	10	21	unrestricted	unrestricted	ADJ
dpc-865	10	22	use	use	NOUN
dpc-865	10	23	,	,	PUNCT
dpc-865	10	24	distribution	distribution	NOUN
dpc-865	10	25	,	,	PUNCT
dpc-865	10	26	and	and	CCONJ
dpc-865	10	27	reproduction	reproduction	NOUN
dpc-865	10	28	in	in	ADP
dpc-865	10	29	any	any	DET
dpc-865	10	30	medium	medium	NOUN
dpc-865	10	31	,	,	PUNCT
dpc-865	10	32	provided	provide	VERB
dpc-865	10	33	the	the	DET
dpc-865	10	34	original	original	ADJ
dpc-865	10	35	author	author	NOUN
dpc-865	10	36	and	and	CCONJ
dpc-865	10	37	source	source	NOUN
dpc-865	10	38	are	be	AUX
dpc-865	10	39	credited	credit	VERB
dpc-865	10	40	.	.	PUNCT
dpc-865	11	1	funding	funding	NOUN
dpc-865	11	2	:	:	PUNCT
dpc-865	11	3	none	none	NOUN
dpc-865	11	4	.	.	PUNCT
dpc-865	12	1	competing	compete	VERB
dpc-865	12	2	interests	interest	NOUN
dpc-865	12	3	:	:	PUNCT
dpc-865	12	4	the	the	DET
dpc-865	12	5	authors	author	NOUN
dpc-865	12	6	have	have	VERB
dpc-865	12	7	no	no	DET
dpc-865	12	8	conflicts	conflict	NOUN
dpc-865	12	9	of	of	ADP
dpc-865	12	10	interest	interest	NOUN
dpc-865	12	11	to	to	PART
dpc-865	12	12	disclose	disclose	VERB
dpc-865	12	13	.	.	PUNCT
dpc-865	13	1	all	all	DET
dpc-865	13	2	authors	author	NOUN
dpc-865	13	3	have	have	AUX
dpc-865	13	4	contributed	contribute	VERB
dpc-865	13	5	significantly	significantly	ADV
dpc-865	13	6	to	to	ADP
dpc-865	13	7	this	this	DET
dpc-865	13	8	publication	publication	NOUN
dpc-865	13	9	.	.	PUNCT
dpc-865	14	1	corresponding	correspond	VERB
dpc-865	14	2	author	author	NOUN
dpc-865	14	3	:	:	PUNCT
dpc-865	14	4	israel	israel	PROPN
dpc-865	14	5	fernandez	fernandez	PROPN
dpc-865	14	6	-	-	PUNCT
dpc-865	14	7	pineda	pineda	PROPN
dpc-865	14	8	,	,	PUNCT
dpc-865	14	9	md	md	PROPN
dpc-865	14	10	,	,	PUNCT
dpc-865	14	11	department	department	NOUN
dpc-865	14	12	of	of	ADP
dpc-865	14	13	pediatric	pediatric	ADJ
dpc-865	14	14	surgery	surgery	NOUN
dpc-865	14	15	,	,	PUNCT
dpc-865	14	16	virgen	virgen	PROPN
dpc-865	14	17	del	del	PROPN
dpc-865	14	18	rocio	rocio	PROPN
dpc-865	14	19	children	children	PROPN
dpc-865	14	20	’s	’s	PART
dpc-865	14	21	hospital	hospital	NOUN
dpc-865	14	22	,	,	PUNCT
dpc-865	15	1	av	av	PROPN
dpc-865	15	2	.	.	PUNCT
dpc-865	15	3	manuel	manuel	PROPN
dpc-865	15	4	siurot	siurot	PROPN
dpc-865	15	5	s	s	PROPN
dpc-865	15	6	/	/	SYM
dpc-865	15	7	n	n	CCONJ
dpc-865	15	8	,	,	PUNCT
dpc-865	15	9	seville	seville	PROPN
dpc-865	15	10	,	,	PUNCT
dpc-865	15	11	spain	spain	PROPN
dpc-865	15	12	.	.	PUNCT
dpc-865	16	1	tel	tel	PROPN
dpc-865	16	2	.	.	PROPN
dpc-865	17	1	34	34	NUM
dpc-865	17	2	955012924	955012924	NUM
dpc-865	17	3	.	.	PUNCT
dpc-865	18	1	email	email	NOUN
dpc-865	18	2	:	:	PUNCT
dpc-865	18	3	israel.fernandez.pineda@gmail.com	israel.fernandez.pineda@gmail.com	X
dpc-865	18	4	kaposiform	kaposiform	VERB
dpc-865	18	5	hemangioendothelioma	hemangioendothelioma	PROPN
dpc-865	18	6	(	(	PUNCT
dpc-865	18	7	khe	khe	PROPN
dpc-865	18	8	)	)	PUNCT
dpc-865	18	9	is	be	AUX
dpc-865	18	10	a	a	DET
dpc-865	18	11	locally	locally	ADV
dpc-865	18	12	aggressive	aggressive	ADJ
dpc-865	18	13	vascular	vascular	ADJ
dpc-865	18	14	tumor	tumor	NOUN
dpc-865	18	15	that	that	PRON
dpc-865	18	16	may	may	AUX
dpc-865	18	17	be	be	AUX
dpc-865	18	18	complicated	complicate	VERB
dpc-865	18	19	by	by	ADP
dpc-865	18	20	kasabach	kasabach	PROPN
dpc-865	18	21	-	-	PUNCT
dpc-865	18	22	merritt	merritt	PROPN
dpc-865	18	23	phenomenon	phenomenon	NOUN
dpc-865	18	24	(	(	PUNCT
dpc-865	18	25	kmp	kmp	PROPN
dpc-865	18	26	)	)	PUNCT
dpc-865	18	27	,	,	PUNCT
dpc-865	18	28	a	a	DET
dpc-865	18	29	profound	profound	ADJ
dpc-865	18	30	thrombocytopenia	thrombocytopenia	NOUN
dpc-865	18	31	resulting	result	VERB
dpc-865	18	32	from	from	ADP
dpc-865	18	33	platelet	platelet	NOUN
dpc-865	18	34	trapping	trapping	NOUN
dpc-865	18	35	within	within	ADP
dpc-865	18	36	a	a	DET
dpc-865	18	37	vascular	vascular	ADJ
dpc-865	18	38	tumor	tumor	NOUN
dpc-865	18	39	,	,	PUNCT
dpc-865	18	40	either	either	CCONJ
dpc-865	18	41	khe	khe	PROPN
dpc-865	18	42	or	or	CCONJ
dpc-865	18	43	tufted	tufte	VERB
dpc-865	18	44	angioma	angioma	NOUN
dpc-865	18	45	(	(	PUNCT
dpc-865	18	46	ta	ta	NOUN
dpc-865	18	47	)	)	PUNCT
dpc-865	18	48	.	.	PUNCT
dpc-865	19	1	typical	typical	ADJ
dpc-865	19	2	features	feature	NOUN
dpc-865	19	3	also	also	ADV
dpc-865	19	4	include	include	VERB
dpc-865	19	5	low	low	ADJ
dpc-865	19	6	fibrinogen	fibrinogen	NOUN
dpc-865	19	7	and	and	CCONJ
dpc-865	19	8	elevated	elevate	VERB
dpc-865	19	9	d	d	NOUN
dpc-865	19	10	-	-	NOUN
dpc-865	19	11	dimers	dimers	NOUN
dpc-865	19	12	.	.	PUNCT
dpc-865	20	1	it	it	PRON
dpc-865	20	2	is	be	AUX
dpc-865	20	3	well	well	ADV
dpc-865	20	4	known	know	VERB
dpc-865	20	5	that	that	SCONJ
dpc-865	20	6	kmp	kmp	PROPN
dpc-865	20	7	is	be	AUX
dpc-865	20	8	not	not	PART
dpc-865	20	9	caused	cause	VERB
dpc-865	20	10	by	by	ADP
dpc-865	20	11	infantile	infantile	ADJ
dpc-865	20	12	hemangiomas	hemangioma	NOUN
dpc-865	20	13	.	.	PUNCT
dpc-865	21	1	management	management	NOUN
dpc-865	21	2	of	of	ADP
dpc-865	21	3	vascular	vascular	ADJ
dpc-865	21	4	tumors	tumor	NOUN
dpc-865	21	5	complicated	complicate	VERB
dpc-865	21	6	by	by	ADP
dpc-865	21	7	kmp	kmp	PROPN
dpc-865	21	8	is	be	AUX
dpc-865	21	9	challenging	challenging	ADJ
dpc-865	21	10	,	,	PUNCT
dpc-865	21	11	and	and	CCONJ
dpc-865	21	12	it	it	PRON
dpc-865	21	13	is	be	AUX
dpc-865	21	14	common	common	ADJ
dpc-865	21	15	for	for	SCONJ
dpc-865	21	16	referral	referral	ADJ
dpc-865	21	17	centers	center	NOUN
dpc-865	21	18	to	to	PART
dpc-865	21	19	receive	receive	VERB
dpc-865	21	20	patients	patient	NOUN
dpc-865	21	21	in	in	ADP
dpc-865	21	22	critical	critical	ADJ
dpc-865	21	23	medical	medical	ADJ
dpc-865	21	24	condition	condition	NOUN
dpc-865	21	25	after	after	ADP
dpc-865	21	26	multimodality	multimodality	NOUN
dpc-865	21	27	treatment	treatment	NOUN
dpc-865	21	28	failure	failure	NOUN
dpc-865	21	29	of	of	ADP
dpc-865	21	30	vascular	vascular	ADJ
dpc-865	21	31	anomalies	anomaly	NOUN
dpc-865	21	32	.	.	PUNCT
dpc-865	22	1	our	our	PRON
dpc-865	22	2	aim	aim	NOUN
dpc-865	22	3	is	be	AUX
dpc-865	22	4	to	to	PART
dpc-865	22	5	communicate	communicate	VERB
dpc-865	22	6	the	the	DET
dpc-865	22	7	importance	importance	NOUN
dpc-865	22	8	of	of	ADP
dpc-865	22	9	early	early	ADJ
dpc-865	22	10	diagnosis	diagnosis	NOUN
dpc-865	22	11	and	and	CCONJ
dpc-865	22	12	treatment	treatment	NOUN
dpc-865	22	13	of	of	ADP
dpc-865	22	14	khe	khe	NOUN
dpc-865	22	15	associated	associate	VERB
dpc-865	22	16	with	with	ADP
dpc-865	22	17	kmp	kmp	PROPN
dpc-865	22	18	.	.	PUNCT
dpc-865	23	1	a	a	DET
dpc-865	23	2	full	full	ADJ
dpc-865	23	3	-	-	PUNCT
dpc-865	23	4	term	term	NOUN
dpc-865	23	5	male	male	NOUN
dpc-865	23	6	newborn	newborn	ADJ
dpc-865	23	7	with	with	ADP
dpc-865	23	8	khe	khe	NOUN
dpc-865	23	9	complicated	complicate	VERB
dpc-865	23	10	by	by	ADP
dpc-865	23	11	kmp	kmp	PROPN
dpc-865	23	12	is	be	AUX
dpc-865	23	13	reported	report	VERB
dpc-865	23	14	.	.	PUNCT
dpc-865	24	1	treatment	treatment	NOUN
dpc-865	24	2	with	with	ADP
dpc-865	24	3	vincristine	vincristine	NOUN
dpc-865	24	4	,	,	PUNCT
dpc-865	24	5	aspirin	aspirin	NOUN
dpc-865	24	6	and	and	CCONJ
dpc-865	24	7	ticlopidine	ticlopidine	NOUN
dpc-865	24	8	normalized	normalize	VERB
dpc-865	24	9	the	the	DET
dpc-865	24	10	coagulation	coagulation	NOUN
dpc-865	24	11	parameters	parameter	NOUN
dpc-865	24	12	within	within	ADP
dpc-865	24	13	one	one	NUM
dpc-865	24	14	week	week	NOUN
dpc-865	24	15	,	,	PUNCT
dpc-865	24	16	requiring	require	VERB
dpc-865	24	17	a	a	DET
dpc-865	24	18	total	total	NOUN
dpc-865	24	19	of	of	ADP
dpc-865	24	20	six	six	NUM
dpc-865	24	21	doses	dose	NOUN
dpc-865	24	22	of	of	ADP
dpc-865	24	23	vincristine	vincristine	NOUN
dpc-865	24	24	,	,	PUNCT
dpc-865	24	25	seven	seven	NUM
dpc-865	24	26	months	month	NOUN
dpc-865	24	27	of	of	ADP
dpc-865	24	28	ticlopidine	ticlopidine	NOUN
dpc-865	24	29	and	and	CCONJ
dpc-865	24	30	17	17	NUM
dpc-865	24	31	months	month	NOUN
dpc-865	24	32	of	of	ADP
dpc-865	24	33	aspirin	aspirin	NOUN
dpc-865	24	34	.	.	PUNCT
dpc-865	25	1	early	early	ADJ
dpc-865	25	2	diagnosis	diagnosis	NOUN
dpc-865	25	3	and	and	CCONJ
dpc-865	25	4	treatment	treatment	NOUN
dpc-865	25	5	of	of	ADP
dpc-865	25	6	khe	khe	NOUN
dpc-865	25	7	complicated	complicate	VERB
dpc-865	25	8	by	by	ADP
dpc-865	25	9	kmp	kmp	PROPN
dpc-865	25	10	may	may	AUX
dpc-865	25	11	allow	allow	VERB
dpc-865	25	12	the	the	DET
dpc-865	25	13	administration	administration	NOUN
dpc-865	25	14	of	of	ADP
dpc-865	25	15	fewer	few	ADJ
dpc-865	25	16	doses	dose	NOUN
dpc-865	25	17	of	of	ADP
dpc-865	25	18	vincristine	vincristine	NOUN
dpc-865	25	19	and	and	CCONJ
dpc-865	25	20	avoid	avoid	VERB
dpc-865	25	21	the	the	DET
dpc-865	25	22	use	use	NOUN
dpc-865	25	23	of	of	ADP
dpc-865	25	24	corticosteroids	corticosteroid	NOUN
dpc-865	25	25	.	.	PUNCT
dpc-865	26	1	abstract	abstract	ADJ
dpc-865	26	2	mailto:israel.fernandez.pineda@gmail.com	mailto:israel.fernandez.pineda@gmail.com	PROPN
dpc-865	27	1	92	92	NUM
dpc-865	27	2	observation	observation	NOUN
dpc-865	27	3	|	|	INTJ
dpc-865	27	4	dermatol	dermatol	NOUN
dpc-865	27	5	pract	pract	PROPN
dpc-865	27	6	concept	concept	NOUN
dpc-865	27	7	2015;5(1):18	2015;5(1):18	NUM
dpc-865	27	8	ing	ing	ADJ
dpc-865	27	9	kmp	kmp	PROPN
dpc-865	28	1	[	[	X
dpc-865	28	2	1	1	NUM
dpc-865	28	3	-	-	SYM
dpc-865	28	4	5	5	NUM
dpc-865	28	5	]	]	PUNCT
dpc-865	28	6	.	.	PUNCT
dpc-865	29	1	in	in	ADP
dpc-865	29	2	an	an	DET
dpc-865	29	3	extensive	extensive	ADJ
dpc-865	29	4	review	review	NOUN
dpc-865	29	5	of	of	ADP
dpc-865	29	6	khe	khe	PROPN
dpc-865	29	7	,	,	PUNCT
dpc-865	29	8	croteau	croteau	VERB
dpc-865	29	9	et	et	NOUN
dpc-865	29	10	al	al	PROPN
dpc-865	30	1	[	[	X
dpc-865	30	2	6	6	NUM
dpc-865	30	3	]	]	PUNCT
dpc-865	30	4	reported	report	VERB
dpc-865	30	5	that	that	SCONJ
dpc-865	30	6	superficial	superficial	ADJ
dpc-865	30	7	tumors	tumor	NOUN
dpc-865	30	8	,	,	PUNCT
dpc-865	30	9	tumors	tumor	NOUN
dpc-865	30	10	isolated	isolate	VERB
dpc-865	30	11	to	to	ADP
dpc-865	30	12	bone	bone	NOUN
dpc-865	30	13	,	,	PUNCT
dpc-865	30	14	or	or	CCONJ
dpc-865	30	15	presentation	presentation	NOUN
dpc-865	30	16	at	at	ADP
dpc-865	30	17	an	an	DET
dpc-865	30	18	older	old	ADJ
dpc-865	30	19	age	age	NOUN
dpc-865	30	20	are	be	AUX
dpc-865	30	21	each	each	PRON
dpc-865	30	22	a	a	DET
dpc-865	30	23	characteristic	characteristic	NOUN
dpc-865	30	24	that	that	PRON
dpc-865	30	25	is	be	AUX
dpc-865	30	26	associated	associate	VERB
dpc-865	30	27	with	with	ADP
dpc-865	30	28	decreased	decrease	VERB
dpc-865	30	29	frequency	frequency	NOUN
dpc-865	30	30	of	of	ADP
dpc-865	30	31	kmp	kmp	PROPN
dpc-865	30	32	.	.	PUNCT
dpc-865	31	1	patients	patient	NOUN
dpc-865	31	2	with	with	ADP
dpc-865	31	3	khe	khe	PROPN
dpc-865	31	4	with	with	ADP
dpc-865	31	5	fascial	fascial	ADJ
dpc-865	31	6	involvement	involvement	NOUN
dpc-865	31	7	but	but	CCONJ
dpc-865	31	8	not	not	PART
dpc-865	31	9	deeper	deep	ADJ
dpc-865	31	10	invasion	invasion	NOUN
dpc-865	31	11	of	of	ADP
dpc-865	31	12	muscle	muscle	NOUN
dpc-865	31	13	or	or	CCONJ
dpc-865	31	14	bone	bone	NOUN
dpc-865	31	15	seem	seem	VERB
dpc-865	31	16	to	to	PART
dpc-865	31	17	present	present	VERB
dpc-865	31	18	with	with	ADP
dpc-865	31	19	few	few	ADJ
dpc-865	31	20	complications	complication	NOUN
dpc-865	31	21	of	of	ADP
dpc-865	31	22	kmp	kmp	PROPN
dpc-865	31	23	.	.	PUNCT
dpc-865	32	1	the	the	DET
dpc-865	32	2	consensus	consensus	NOUN
dpc-865	32	3	-	-	PUNCT
dpc-865	32	4	derived	derive	VERB
dpc-865	32	5	practice	practice	NOUN
dpc-865	32	6	standards	standard	NOUN
dpc-865	32	7	plan	plan	NOUN
dpc-865	32	8	for	for	ADP
dpc-865	32	9	complicated	complicated	ADJ
dpc-865	32	10	khe	khe	NOUN
dpc-865	32	11	was	be	AUX
dpc-865	32	12	published	publish	VERB
dpc-865	32	13	in	in	ADP
dpc-865	32	14	2013	2013	NUM
dpc-865	32	15	and	and	CCONJ
dpc-865	32	16	reported	report	VERB
dpc-865	32	17	that	that	SCONJ
dpc-865	32	18	64	64	NUM
dpc-865	32	19	%	%	NOUN
dpc-865	32	20	of	of	ADP
dpc-865	32	21	experts	expert	NOUN
dpc-865	32	22	’	'	PUNCT
dpc-865	32	23	centers	center	NOUN
dpc-865	32	24	did	do	AUX
dpc-865	32	25	not	not	PART
dpc-865	32	26	think	think	VERB
dpc-865	32	27	that	that	SCONJ
dpc-865	32	28	a	a	DET
dpc-865	32	29	tissue	tissue	NOUN
dpc-865	32	30	biopsy	biopsy	NOUN
dpc-865	32	31	was	be	AUX
dpc-865	32	32	necessary	necessary	ADJ
dpc-865	32	33	to	to	PART
dpc-865	32	34	confirm	confirm	VERB
dpc-865	32	35	diagnosis	diagnosis	NOUN
dpc-865	32	36	of	of	ADP
dpc-865	32	37	kmp	kmp	NOUN
dpc-865	33	1	[	[	X
dpc-865	33	2	7	7	NUM
dpc-865	33	3	]	]	PUNCT
dpc-865	33	4	.	.	PUNCT
dpc-865	34	1	as	as	ADP
dpc-865	34	2	in	in	ADP
dpc-865	34	3	our	our	PRON
dpc-865	34	4	case	case	NOUN
dpc-865	34	5	,	,	PUNCT
dpc-865	34	6	most	most	ADJ
dpc-865	34	7	of	of	ADP
dpc-865	34	8	the	the	DET
dpc-865	34	9	patients	patient	NOUN
dpc-865	34	10	present	present	ADJ
dpc-865	34	11	are	be	AUX
dpc-865	34	12	diagnosed	diagnose	VERB
dpc-865	34	13	based	base	VERB
dpc-865	34	14	on	on	ADP
dpc-865	34	15	clinical	clinical	ADJ
dpc-865	34	16	,	,	PUNCT
dpc-865	34	17	imaging	imaging	NOUN
dpc-865	34	18	and	and	CCONJ
dpc-865	34	19	laboratory	laboratory	NOUN
dpc-865	34	20	findings	finding	NOUN
dpc-865	34	21	(	(	PUNCT
dpc-865	34	22	profound	profound	ADJ
dpc-865	34	23	thrombocytopenia	thrombocytopenia	NOUN
dpc-865	34	24	and	and	CCONJ
dpc-865	34	25	elevated	elevate	VERB
dpc-865	34	26	serum	serum	NOUN
dpc-865	34	27	d	d	NOUN
dpc-865	34	28	-	-	PUNCT
dpc-865	34	29	dimer	dimer	NOUN
dpc-865	34	30	)	)	PUNCT
dpc-865	34	31	.	.	PUNCT
dpc-865	35	1	diagnosis	diagnosis	NOUN
dpc-865	35	2	of	of	ADP
dpc-865	35	3	khe	khe	NOUN
dpc-865	35	4	associated	associate	VERB
dpc-865	35	5	with	with	ADP
dpc-865	35	6	kmp	kmp	PROPN
dpc-865	35	7	is	be	AUX
dpc-865	35	8	usually	usually	ADV
dpc-865	35	9	delayed	delay	VERB
dpc-865	35	10	,	,	PUNCT
dpc-865	35	11	and	and	CCONJ
dpc-865	35	12	several	several	ADJ
dpc-865	35	13	factors	factor	NOUN
dpc-865	35	14	may	may	AUX
dpc-865	35	15	be	be	AUX
dpc-865	35	16	implicated	implicate	VERB
dpc-865	35	17	such	such	ADJ
dpc-865	35	18	as	as	ADP
dpc-865	35	19	lack	lack	NOUN
dpc-865	35	20	of	of	ADP
dpc-865	35	21	experience	experience	NOUN
dpc-865	35	22	in	in	ADP
dpc-865	35	23	clinical	clinical	ADJ
dpc-865	35	24	diagnosis	diagnosis	NOUN
dpc-865	35	25	of	of	ADP
dpc-865	35	26	vascular	vascular	ADJ
dpc-865	35	27	anomalies	anomaly	NOUN
dpc-865	35	28	,	,	PUNCT
dpc-865	35	29	deep	deep	ADJ
dpc-865	35	30	tumor	tumor	NOUN
dpc-865	35	31	location	location	NOUN
dpc-865	35	32	(	(	PUNCT
dpc-865	35	33	mediastinum	mediastinum	ADJ
dpc-865	35	34	,	,	PUNCT
dpc-865	35	35	retroperitoneum	retroperitoneum	NOUN
dpc-865	35	36	)	)	PUNCT
dpc-865	35	37	and/or	and/or	CCONJ
dpc-865	35	38	the	the	DET
dpc-865	35	39	coagulation	coagulation	NOUN
dpc-865	35	40	abnormalities	abnormality	NOUN
dpc-865	35	41	that	that	PRON
dpc-865	35	42	makes	make	VERB
dpc-865	35	43	the	the	DET
dpc-865	35	44	biopsy	biopsy	NOUN
dpc-865	35	45	challenging	challenging	ADJ
dpc-865	35	46	.	.	PUNCT
dpc-865	36	1	differential	differential	ADJ
dpc-865	36	2	diagnosis	diagnosis	NOUN
dpc-865	36	3	with	with	ADP
dpc-865	36	4	other	other	ADJ
dpc-865	36	5	tumors	tumor	NOUN
dpc-865	36	6	that	that	PRON
dpc-865	36	7	may	may	AUX
dpc-865	36	8	cause	cause	VERB
dpc-865	36	9	coagulopathy	coagulopathy	ADJ
dpc-865	36	10	should	should	AUX
dpc-865	36	11	be	be	AUX
dpc-865	36	12	performed	perform	VERB
dpc-865	36	13	.	.	PUNCT
dpc-865	37	1	baselga	baselga	ADJ
dpc-865	37	2	et	et	PROPN
dpc-865	37	3	al	al	PROPN
dpc-865	38	1	[	[	X
dpc-865	38	2	8	8	NUM
dpc-865	38	3	]	]	PUNCT
dpc-865	38	4	described	describe	VERB
dpc-865	38	5	that	that	SCONJ
dpc-865	38	6	rapidly	rapidly	ADV
dpc-865	38	7	involuting	involute	VERB
dpc-865	38	8	congenital	congenital	ADJ
dpc-865	38	9	hemangioma	hemangioma	NOUN
dpc-865	38	10	(	(	PUNCT
dpc-865	38	11	rich	rich	ADJ
dpc-865	38	12	)	)	PUNCT
dpc-865	38	13	may	may	AUX
dpc-865	38	14	present	present	VERB
dpc-865	38	15	with	with	ADP
dpc-865	38	16	thrombocytopenia	thrombocytopenia	NOUN
dpc-865	38	17	and	and	CCONJ
dpc-865	38	18	coagulopathy	coagulopathy	ADJ
dpc-865	38	19	similar	similar	ADJ
dpc-865	38	20	to	to	ADP
dpc-865	38	21	mild	mild	ADJ
dpc-865	38	22	kmp	kmp	NOUN
dpc-865	38	23	early	early	ADV
dpc-865	38	24	in	in	ADP
dpc-865	38	25	the	the	DET
dpc-865	38	26	neoa	neoa	NOUN
dpc-865	38	27	multichanneled	multichannele	VERB
dpc-865	38	28	fast	fast	ADV
dpc-865	38	29	-	-	PUNCT
dpc-865	38	30	flowing	flow	VERB
dpc-865	38	31	vascular	vascular	ADJ
dpc-865	38	32	tumor	tumor	NOUN
dpc-865	38	33	.	.	PUNCT
dpc-865	39	1	clinical	clinical	ADJ
dpc-865	39	2	appearance	appearance	NOUN
dpc-865	39	3	of	of	ADP
dpc-865	39	4	the	the	DET
dpc-865	39	5	tumor	tumor	NOUN
dpc-865	39	6	,	,	PUNCT
dpc-865	39	7	radiological	radiological	ADJ
dpc-865	39	8	findings	finding	NOUN
dpc-865	39	9	,	,	PUNCT
dpc-865	39	10	and	and	CCONJ
dpc-865	39	11	the	the	DET
dpc-865	39	12	coexisting	coexist	VERB
dpc-865	39	13	kmp	kmp	PROPN
dpc-865	39	14	supported	support	VERB
dpc-865	39	15	the	the	DET
dpc-865	39	16	diagnosis	diagnosis	NOUN
dpc-865	39	17	of	of	ADP
dpc-865	39	18	kaposiform	kaposiform	NOUN
dpc-865	39	19	hemangioendothelioma	hemangioendothelioma	NOUN
dpc-865	39	20	(	(	PUNCT
dpc-865	39	21	khe	khe	PROPN
dpc-865	39	22	)	)	PUNCT
dpc-865	39	23	.	.	PUNCT
dpc-865	40	1	treatment	treatment	NOUN
dpc-865	40	2	was	be	AUX
dpc-865	40	3	according	accord	VERB
dpc-865	40	4	to	to	AUX
dpc-865	40	5	seop	seop	VERB
dpc-865	40	6	(	(	PUNCT
dpc-865	40	7	spanish	spanish	ADJ
dpc-865	40	8	society	society	NOUN
dpc-865	40	9	of	of	ADP
dpc-865	40	10	pediatric	pediatric	ADJ
dpc-865	40	11	oncology	oncology	NOUN
dpc-865	40	12	)	)	PUNCT
dpc-865	40	13	guidelines	guideline	NOUN
dpc-865	40	14	for	for	ADP
dpc-865	40	15	vascular	vascular	ADJ
dpc-865	40	16	tumors	tumor	NOUN
dpc-865	40	17	complicated	complicate	VERB
dpc-865	40	18	by	by	ADP
dpc-865	40	19	kmp	kmp	PROPN
dpc-865	40	20	and	and	CCONJ
dpc-865	40	21	included	include	VERB
dpc-865	40	22	vincristine	vincristine	NOUN
dpc-865	40	23	,	,	PUNCT
dpc-865	40	24	aspirin	aspirin	NOUN
dpc-865	40	25	and	and	CCONJ
dpc-865	40	26	ticlopidine	ticlopidine	NOUN
dpc-865	40	27	(	(	PUNCT
dpc-865	40	28	vat	vat	NOUN
dpc-865	40	29	therapy	therapy	NOUN
dpc-865	40	30	)	)	PUNCT
dpc-865	40	31	.	.	PUNCT
dpc-865	41	1	the	the	DET
dpc-865	41	2	patient	patient	NOUN
dpc-865	41	3	received	receive	VERB
dpc-865	41	4	vat	vat	NOUN
dpc-865	41	5	therapy	therapy	NOUN
dpc-865	41	6	with	with	ADP
dpc-865	41	7	vincristine	vincristine	NOUN
dpc-865	41	8	:	:	PUNCT
dpc-865	41	9	0.05	0.05	NUM
dpc-865	41	10	mg	mg	PROPN
dpc-865	41	11	/	/	SYM
dpc-865	41	12	kg	kg	NOUN
dpc-865	41	13	weekly	weekly	NOUN
dpc-865	41	14	;	;	PUNCT
dpc-865	41	15	aspirin	aspirin	NOUN
dpc-865	41	16	:	:	PUNCT
dpc-865	41	17	10	10	NUM
dpc-865	41	18	mg	mg	NUM
dpc-865	41	19	/	/	SYM
dpc-865	41	20	kg	kg	PROPN
dpc-865	41	21	/	/	SYM
dpc-865	41	22	day	day	NOUN
dpc-865	41	23	;	;	PUNCT
dpc-865	41	24	and	and	CCONJ
dpc-865	41	25	ticlopidine	ticlopidine	NOUN
dpc-865	41	26	:	:	PUNCT
dpc-865	41	27	10	10	NUM
dpc-865	41	28	mg/	mg/	ADJ
dpc-865	41	29	kg	kg	PROPN
dpc-865	41	30	/	/	SYM
dpc-865	41	31	day	day	NOUN
dpc-865	41	32	.	.	PUNCT
dpc-865	42	1	treatment	treatment	NOUN
dpc-865	42	2	response	response	NOUN
dpc-865	42	3	was	be	AUX
dpc-865	42	4	based	base	VERB
dpc-865	42	5	on	on	ADP
dpc-865	42	6	platelet	platelet	NOUN
dpc-865	42	7	count	count	NOUN
dpc-865	42	8	and	and	CCONJ
dpc-865	42	9	classified	classify	VERB
dpc-865	42	10	as	as	ADP
dpc-865	42	11	good	good	ADJ
dpc-865	42	12	response	response	NOUN
dpc-865	42	13	(	(	PUNCT
dpc-865	42	14	increase	increase	NOUN
dpc-865	42	15	of	of	ADP
dpc-865	42	16	>	>	PUNCT
dpc-865	42	17	50	50	NUM
dpc-865	42	18	%	%	NOUN
dpc-865	42	19	of	of	ADP
dpc-865	42	20	platelet	platelet	NOUN
dpc-865	42	21	count	count	NOUN
dpc-865	42	22	)	)	PUNCT
dpc-865	42	23	observed	observe	VERB
dpc-865	42	24	in	in	ADP
dpc-865	42	25	obtained	obtain	VERB
dpc-865	42	26	blood	blood	NOUN
dpc-865	42	27	tests	test	NOUN
dpc-865	42	28	no	no	ADV
dpc-865	42	29	longer	long	ADV
dpc-865	42	30	than	than	ADP
dpc-865	42	31	three	three	NUM
dpc-865	42	32	weeks	week	NOUN
dpc-865	42	33	since	since	SCONJ
dpc-865	42	34	the	the	DET
dpc-865	42	35	treatment	treatment	NOUN
dpc-865	42	36	was	be	AUX
dpc-865	42	37	started	start	VERB
dpc-865	42	38	and	and	CCONJ
dpc-865	42	39	repeated	repeat	VERB
dpc-865	42	40	every	every	DET
dpc-865	42	41	two	two	NUM
dpc-865	42	42	weeks	week	NOUN
dpc-865	42	43	.	.	PUNCT
dpc-865	43	1	coagulation	coagulation	NOUN
dpc-865	43	2	parameters	parameter	NOUN
dpc-865	43	3	normalized	normalize	VERB
dpc-865	43	4	within	within	ADP
dpc-865	43	5	one	one	NUM
dpc-865	43	6	week	week	NOUN
dpc-865	43	7	,	,	PUNCT
dpc-865	43	8	along	along	ADP
dpc-865	43	9	with	with	ADP
dpc-865	43	10	the	the	DET
dpc-865	43	11	decrease	decrease	NOUN
dpc-865	43	12	in	in	ADP
dpc-865	43	13	size	size	NOUN
dpc-865	43	14	of	of	ADP
dpc-865	43	15	the	the	DET
dpc-865	43	16	tumor	tumor	NOUN
dpc-865	43	17	.	.	PUNCT
dpc-865	44	1	the	the	DET
dpc-865	44	2	patient	patient	NOUN
dpc-865	44	3	required	require	VERB
dpc-865	44	4	a	a	DET
dpc-865	44	5	total	total	NOUN
dpc-865	44	6	of	of	ADP
dpc-865	44	7	six	six	NUM
dpc-865	44	8	doses	dose	NOUN
dpc-865	44	9	of	of	ADP
dpc-865	44	10	vincristine	vincristine	NOUN
dpc-865	44	11	,	,	PUNCT
dpc-865	44	12	seven	seven	NUM
dpc-865	44	13	months	month	NOUN
dpc-865	44	14	of	of	ADP
dpc-865	44	15	ticlopidine	ticlopidine	NOUN
dpc-865	44	16	and	and	CCONJ
dpc-865	44	17	17	17	NUM
dpc-865	44	18	months	month	NOUN
dpc-865	44	19	of	of	ADP
dpc-865	44	20	aspirin	aspirin	NOUN
dpc-865	44	21	.	.	PUNCT
dpc-865	45	1	twelve	twelve	NUM
dpc-865	45	2	months	month	NOUN
dpc-865	45	3	after	after	ADP
dpc-865	45	4	discontinuation	discontinuation	NOUN
dpc-865	45	5	of	of	ADP
dpc-865	45	6	aspirin	aspirin	NOUN
dpc-865	45	7	,	,	PUNCT
dpc-865	45	8	the	the	DET
dpc-865	45	9	patient	patient	NOUN
dpc-865	45	10	remains	remain	VERB
dpc-865	45	11	asymptomatic	asymptomatic	ADJ
dpc-865	45	12	with	with	ADP
dpc-865	45	13	no	no	DET
dpc-865	45	14	tumor	tumor	NOUN
dpc-865	45	15	regrowth	regrowth	NOUN
dpc-865	45	16	and	and	CCONJ
dpc-865	45	17	normal	normal	ADJ
dpc-865	45	18	platelet	platelet	NOUN
dpc-865	45	19	count	count	NOUN
dpc-865	45	20	.	.	PUNCT
dpc-865	46	1	discussion	discussion	NOUN
dpc-865	46	2	khe	khe	PROPN
dpc-865	46	3	involves	involve	VERB
dpc-865	46	4	a	a	DET
dpc-865	46	5	spectrum	spectrum	NOUN
dpc-865	46	6	of	of	ADP
dpc-865	46	7	lesions	lesion	NOUN
dpc-865	46	8	from	from	ADP
dpc-865	46	9	small	small	ADJ
dpc-865	46	10	,	,	PUNCT
dpc-865	46	11	superficial	superficial	ADJ
dpc-865	46	12	tumors	tumor	NOUN
dpc-865	46	13	without	without	ADP
dpc-865	46	14	kmp	kmp	PROPN
dpc-865	46	15	to	to	PART
dpc-865	46	16	large	large	ADJ
dpc-865	46	17	,	,	PUNCT
dpc-865	46	18	infiltrative	infiltrative	ADJ
dpc-865	46	19	lesions	lesion	NOUN
dpc-865	46	20	with	with	ADP
dpc-865	46	21	life	life	NOUN
dpc-865	46	22	-	-	PUNCT
dpc-865	46	23	threatening	threaten	VERB
dpc-865	46	24	complications	complication	NOUN
dpc-865	46	25	includfigure	includfigure	VERB
dpc-865	46	26	1	1	NUM
dpc-865	46	27	.	.	PUNCT
dpc-865	47	1	right	right	ADJ
dpc-865	47	2	latero	latero	NOUN
dpc-865	47	3	-	-	PUNCT
dpc-865	47	4	cervical	cervical	ADJ
dpc-865	47	5	kaposiform	kaposiform	NOUN
dpc-865	47	6	hemangioendothelioma	hemangioendothelioma	NOUN
dpc-865	47	7	at	at	ADP
dpc-865	47	8	birth	birth	NOUN
dpc-865	47	9	(	(	PUNCT
dpc-865	47	10	a	a	NOUN
dpc-865	47	11	)	)	PUNCT
dpc-865	47	12	and	and	CCONJ
dpc-865	47	13	17	17	NUM
dpc-865	47	14	months	month	NOUN
dpc-865	47	15	later	later	ADV
dpc-865	47	16	,	,	PUNCT
dpc-865	47	17	after	after	ADP
dpc-865	47	18	completion	completion	NOUN
dpc-865	47	19	of	of	ADP
dpc-865	47	20	therapy	therapy	NOUN
dpc-865	47	21	(	(	PUNCT
dpc-865	47	22	b	b	NOUN
dpc-865	47	23	)	)	PUNCT
dpc-865	47	24	.	.	PUNCT
dpc-865	48	1	(	(	PUNCT
dpc-865	48	2	copyright	copyright	NOUN
dpc-865	48	3	:	:	PUNCT
dpc-865	48	4	©	©	PROPN
dpc-865	48	5	2015	2015	NUM
dpc-865	48	6	vivas	viva	NOUN
dpc-865	48	7	-	-	NOUN
dpc-865	48	8	colmenares	colmenare	NOUN
dpc-865	48	9	et	et	PROPN
dpc-865	48	10	al	al	PROPN
dpc-865	48	11	.	.	PROPN
dpc-865	48	12	)	)	PUNCT
dpc-865	48	13	natal	natal	ADJ
dpc-865	48	14	period	period	NOUN
dpc-865	48	15	.	.	PUNCT
dpc-865	49	1	however	however	ADV
dpc-865	49	2	,	,	PUNCT
dpc-865	49	3	in	in	ADP
dpc-865	49	4	contrast	contrast	NOUN
dpc-865	49	5	to	to	ADP
dpc-865	49	6	true	true	ADJ
dpc-865	49	7	kmp	kmp	PROPN
dpc-865	49	8	,	,	PUNCT
dpc-865	49	9	these	these	DET
dpc-865	49	10	abnormal	abnormal	ADJ
dpc-865	49	11	laboratory	laboratory	NOUN
dpc-865	49	12	findings	finding	NOUN
dpc-865	49	13	are	be	AUX
dpc-865	49	14	self	self	NOUN
dpc-865	49	15	-	-	PUNCT
dpc-865	49	16	limited	limit	VERB
dpc-865	49	17	and	and	CCONJ
dpc-865	49	18	are	be	AUX
dpc-865	49	19	usually	usually	ADV
dpc-865	49	20	not	not	PART
dpc-865	49	21	complicated	complicate	VERB
dpc-865	49	22	by	by	ADP
dpc-865	49	23	bleeding	bleed	VERB
dpc-865	49	24	problems	problem	NOUN
dpc-865	49	25	.	.	PUNCT
dpc-865	50	1	rich	rich	ADJ
dpc-865	50	2	is	be	AUX
dpc-865	50	3	fully	fully	ADV
dpc-865	50	4	formed	form	VERB
dpc-865	50	5	at	at	ADP
dpc-865	50	6	birth	birth	NOUN
dpc-865	50	7	and	and	CCONJ
dpc-865	50	8	it	it	PRON
dpc-865	50	9	does	do	AUX
dpc-865	50	10	not	not	PART
dpc-865	50	11	enlarge	enlarge	VERB
dpc-865	50	12	within	within	ADP
dpc-865	50	13	the	the	DET
dpc-865	50	14	first	first	ADJ
dpc-865	50	15	weeks	week	NOUN
dpc-865	50	16	of	of	ADP
dpc-865	50	17	life	life	NOUN
dpc-865	50	18	.	.	PUNCT
dpc-865	51	1	clinical	clinical	ADJ
dpc-865	51	2	appearance	appearance	NOUN
dpc-865	51	3	of	of	ADP
dpc-865	51	4	rich	rich	ADJ
dpc-865	51	5	is	be	AUX
dpc-865	51	6	characterized	characterize	VERB
dpc-865	51	7	by	by	ADP
dpc-865	51	8	superficial	superficial	ADJ
dpc-865	51	9	prominent	prominent	ADJ
dpc-865	51	10	veins	vein	NOUN
dpc-865	51	11	and	and	CCONJ
dpc-865	51	12	is	be	AUX
dpc-865	51	13	encircled	encircle	VERB
dpc-865	51	14	by	by	ADP
dpc-865	51	15	a	a	DET
dpc-865	51	16	pale	pale	ADJ
dpc-865	51	17	halo	halo	NOUN
dpc-865	51	18	,	,	PUNCT
dpc-865	51	19	while	while	SCONJ
dpc-865	51	20	khe	khe	PROPN
dpc-865	51	21	is	be	AUX
dpc-865	51	22	a	a	DET
dpc-865	51	23	plaque	plaque	NOUN
dpc-865	51	24	-	-	PUNCT
dpc-865	51	25	like	like	ADJ
dpc-865	51	26	lesion	lesion	NOUN
dpc-865	51	27	with	with	ADP
dpc-865	51	28	ecchymosis	ecchymosis	NOUN
dpc-865	51	29	.	.	PUNCT
dpc-865	52	1	a	a	DET
dpc-865	52	2	biopsy	biopsy	NOUN
dpc-865	52	3	would	would	AUX
dpc-865	52	4	have	have	AUX
dpc-865	52	5	been	be	AUX
dpc-865	52	6	useful	useful	ADJ
dpc-865	52	7	to	to	PART
dpc-865	52	8	obtain	obtain	VERB
dpc-865	52	9	a	a	DET
dpc-865	52	10	histological	histological	ADJ
dpc-865	52	11	diagnosis	diagnosis	NOUN
dpc-865	52	12	in	in	ADP
dpc-865	52	13	our	our	PRON
dpc-865	52	14	case	case	NOUN
dpc-865	52	15	,	,	PUNCT
dpc-865	52	16	but	but	CCONJ
dpc-865	52	17	the	the	DET
dpc-865	52	18	patient	patient	NOUN
dpc-865	52	19	presented	present	VERB
dpc-865	52	20	a	a	DET
dpc-865	52	21	profound	profound	ADJ
dpc-865	52	22	thrombocytopenia	thrombocytopenia	NOUN
dpc-865	52	23	and	and	CCONJ
dpc-865	52	24	severe	severe	ADJ
dpc-865	52	25	abnormalities	abnormality	NOUN
dpc-865	52	26	in	in	ADP
dpc-865	52	27	coagulation	coagulation	NOUN
dpc-865	52	28	parameters	parameter	NOUN
dpc-865	52	29	,	,	PUNCT
dpc-865	52	30	which	which	PRON
dpc-865	52	31	made	make	VERB
dpc-865	52	32	the	the	DET
dpc-865	52	33	biopsy	biopsy	NOUN
dpc-865	52	34	a	a	DET
dpc-865	52	35	high	high	ADJ
dpc-865	52	36	-	-	PUNCT
dpc-865	52	37	risk	risk	NOUN
dpc-865	52	38	bleeding	bleeding	NOUN
dpc-865	52	39	procedure	procedure	NOUN
dpc-865	52	40	.	.	PUNCT
dpc-865	53	1	on	on	ADP
dpc-865	53	2	imaging	image	VERB
dpc-865	53	3	studies	study	NOUN
dpc-865	53	4	(	(	PUNCT
dpc-865	53	5	mri	mri	NOUN
dpc-865	53	6	,	,	PUNCT
dpc-865	53	7	doppler	doppler	NOUN
dpc-865	53	8	-	-	PUNCT
dpc-865	53	9	us	we	PRON
dpc-865	53	10	)	)	PUNCT
dpc-865	53	11	,	,	PUNCT
dpc-865	53	12	both	both	DET
dpc-865	53	13	tumors	tumor	NOUN
dpc-865	53	14	are	be	AUX
dpc-865	53	15	highly	highly	ADV
dpc-865	53	16	vascularized	vascularized	ADJ
dpc-865	53	17	lesions	lesion	NOUN
dpc-865	53	18	with	with	ADP
dpc-865	53	19	highflow	highflow	NOUN
dpc-865	53	20	,	,	PUNCT
dpc-865	53	21	but	but	CCONJ
dpc-865	53	22	khe	khe	PROPN
dpc-865	53	23	has	have	VERB
dpc-865	53	24	a	a	DET
dpc-865	53	25	more	more	ADV
dpc-865	53	26	infiltrative	infiltrative	ADJ
dpc-865	53	27	pattern	pattern	NOUN
dpc-865	53	28	compared	compare	VERB
dpc-865	53	29	to	to	ADP
dpc-865	53	30	rich	rich	ADJ
dpc-865	53	31	.	.	PUNCT
dpc-865	54	1	evaluation	evaluation	NOUN
dpc-865	54	2	of	of	ADP
dpc-865	54	3	treatment	treatment	NOUN
dpc-865	54	4	outcomes	outcome	NOUN
dpc-865	54	5	is	be	AUX
dpc-865	54	6	difficult	difficult	ADJ
dpc-865	54	7	and	and	CCONJ
dpc-865	54	8	based	base	VERB
dpc-865	54	9	on	on	ADP
dpc-865	54	10	personal	personal	ADJ
dpc-865	54	11	opinions	opinion	NOUN
dpc-865	54	12	,	,	PUNCT
dpc-865	54	13	isolated	isolated	ADJ
dpc-865	54	14	case	case	NOUN
dpc-865	54	15	reports	report	NOUN
dpc-865	54	16	and	and	CCONJ
dpc-865	54	17	small	small	ADJ
dpc-865	54	18	series	series	NOUN
dpc-865	54	19	.	.	PUNCT
dpc-865	55	1	most	most	ADJ
dpc-865	55	2	of	of	ADP
dpc-865	55	3	the	the	DET
dpc-865	55	4	patients	patient	NOUN
dpc-865	55	5	receive	receive	VERB
dpc-865	55	6	multimodality	multimodality	NOUN
dpc-865	55	7	therapy	therapy	NOUN
dpc-865	55	8	,	,	PUNCT
dpc-865	55	9	and	and	CCONJ
dpc-865	55	10	some	some	DET
dpc-865	55	11	delays	delay	NOUN
dpc-865	55	12	of	of	ADP
dpc-865	55	13	initiation	initiation	NOUN
dpc-865	55	14	of	of	ADP
dpc-865	55	15	therapy	therapy	NOUN
dpc-865	55	16	may	may	AUX
dpc-865	55	17	cause	cause	VERB
dpc-865	55	18	significant	significant	ADJ
dpc-865	55	19	morbidity	morbidity	NOUN
dpc-865	55	20	and	and	CCONJ
dpc-865	55	21	mortality	mortality	NOUN
dpc-865	55	22	.	.	PUNCT
dpc-865	56	1	the	the	DET
dpc-865	56	2	literature	literature	NOUN
dpc-865	56	3	describes	describe	VERB
dpc-865	56	4	a	a	DET
dpc-865	56	5	variable	variable	ADJ
dpc-865	56	6	response	response	NOUN
dpc-865	56	7	to	to	ADP
dpc-865	56	8	corticosteroid	corticosteroid	NOUN
dpc-865	56	9	therapy	therapy	NOUN
dpc-865	56	10	(	(	PUNCT
dpc-865	56	11	20–70	20–70	NUM
dpc-865	56	12	%	%	NOUN
dpc-865	56	13	)	)	PUNCT
dpc-865	56	14	,	,	PUNCT
dpc-865	56	15	and	and	CCONJ
dpc-865	56	16	depending	depend	VERB
dpc-865	56	17	on	on	ADP
dpc-865	56	18	the	the	DET
dpc-865	56	19	dosage	dosage	NOUN
dpc-865	56	20	can	can	AUX
dpc-865	56	21	cause	cause	VERB
dpc-865	56	22	several	several	ADJ
dpc-865	56	23	adverse	adverse	ADJ
dpc-865	56	24	side	side	NOUN
dpc-865	56	25	effects	effect	NOUN
dpc-865	56	26	such	such	ADJ
dpc-865	56	27	as	as	ADP
dpc-865	56	28	severe	severe	ADJ
dpc-865	56	29	hypertension	hypertension	NOUN
dpc-865	56	30	,	,	PUNCT
dpc-865	56	31	growth	growth	NOUN
dpc-865	56	32	restriction	restriction	NOUN
dpc-865	56	33	,	,	PUNCT
dpc-865	56	34	and	and	CCONJ
dpc-865	56	35	osteoporosis	osteoporosis	NOUN
dpc-865	56	36	[	[	X
dpc-865	56	37	9,10	9,10	NUM
dpc-865	56	38	]	]	PUNCT
dpc-865	56	39	.	.	PUNCT
dpc-865	57	1	although	although	SCONJ
dpc-865	57	2	case	case	NOUN
dpc-865	57	3	reports	report	NOUN
dpc-865	57	4	have	have	AUX
dpc-865	57	5	described	describe	VERB
dpc-865	57	6	the	the	DET
dpc-865	57	7	efficacy	efficacy	NOUN
dpc-865	57	8	of	of	ADP
dpc-865	57	9	propranolol	propranolol	PROPN
dpc-865	57	10	for	for	ADP
dpc-865	57	11	the	the	DET
dpc-865	57	12	treatment	treatment	NOUN
dpc-865	57	13	of	of	ADP
dpc-865	57	14	khe	khe	PROPN
dpc-865	57	15	,	,	PUNCT
dpc-865	57	16	chiu	chiu	PROPN
dpc-865	57	17	et	et	PROPN
dpc-865	57	18	al	al	PROPN
dpc-865	58	1	[	[	X
dpc-865	58	2	11	11	NUM
dpc-865	58	3	]	]	PUNCT
dpc-865	58	4	found	find	VERB
dpc-865	58	5	that	that	SCONJ
dpc-865	58	6	propranolol	propranolol	PROPN
dpc-865	58	7	was	be	AUX
dpc-865	58	8	ineffective	ineffective	ADJ
dpc-865	58	9	in	in	ADP
dpc-865	58	10	seven	seven	NUM
dpc-865	58	11	of	of	ADP
dpc-865	58	12	their	their	PRON
dpc-865	58	13	eleven	eleven	NUM
dpc-865	58	14	patients	patient	NOUN
dpc-865	58	15	and	and	CCONJ
dpc-865	58	16	recommend	recommend	VERB
dpc-865	58	17	clinicians	clinician	NOUN
dpc-865	58	18	to	to	PART
dpc-865	58	19	proceed	proceed	VERB
dpc-865	58	20	cautiously	cautiously	ADV
dpc-865	58	21	before	before	ADP
dpc-865	58	22	treating	treat	VERB
dpc-865	58	23	these	these	DET
dpc-865	58	24	life	life	NOUN
dpc-865	58	25	-	-	PUNCT
dpc-865	58	26	threatening	threaten	VERB
dpc-865	58	27	conditions	condition	NOUN
dpc-865	58	28	with	with	ADP
dpc-865	58	29	propranolol	propranolol	NOUN
dpc-865	58	30	.	.	PUNCT
dpc-865	59	1	recently	recently	ADV
dpc-865	59	2	,	,	PUNCT
dpc-865	59	3	sirolimus	sirolimus	PROPN
dpc-865	59	4	has	have	AUX
dpc-865	59	5	been	be	AUX
dpc-865	59	6	described	describe	VERB
dpc-865	59	7	to	to	PART
dpc-865	59	8	be	be	AUX
dpc-865	59	9	effective	effective	ADJ
dpc-865	59	10	and	and	CCONJ
dpc-865	59	11	safe	safe	ADJ
dpc-865	59	12	in	in	ADP
dpc-865	59	13	patients	patient	NOUN
dpc-865	59	14	with	with	ADP
dpc-865	59	15	life	life	NOUN
dpc-865	59	16	-	-	PUNCT
dpc-865	59	17	threatening	threaten	VERB
dpc-865	59	18	khe	khe	NOUN
dpc-865	59	19	and	and	CCONJ
dpc-865	59	20	may	may	AUX
dpc-865	59	21	represent	represent	VERB
dpc-865	59	22	a	a	DET
dpc-865	59	23	promising	promising	ADJ
dpc-865	59	24	tool	tool	NOUN
dpc-865	59	25	in	in	ADP
dpc-865	59	26	treating	treat	VERB
dpc-865	59	27	refractory	refractory	NOUN
dpc-865	59	28	khe	khe	NOUN
dpc-865	60	1	[	[	X
dpc-865	60	2	12	12	NUM
dpc-865	60	3	]	]	PUNCT
dpc-865	60	4	.	.	PUNCT
dpc-865	61	1	vincristine	vincristine	PROPN
dpc-865	61	2	is	be	AUX
dpc-865	61	3	usually	usually	ADV
dpc-865	61	4	used	use	VERB
dpc-865	61	5	in	in	ADP
dpc-865	61	6	combination	combination	NOUN
dpc-865	61	7	with	with	ADP
dpc-865	61	8	other	other	ADJ
dpc-865	61	9	therapies	therapy	NOUN
dpc-865	61	10	for	for	ADP
dpc-865	61	11	severe	severe	ADJ
dpc-865	61	12	,	,	PUNCT
dpc-865	61	13	life	life	NOUN
dpc-865	61	14	-	-	PUNCT
dpc-865	61	15	threatening	threaten	VERB
dpc-865	61	16	cases	case	NOUN
dpc-865	61	17	because	because	SCONJ
dpc-865	61	18	of	of	ADP
dpc-865	61	19	its	its	PRON
dpc-865	61	20	good	good	ADJ
dpc-865	61	21	tolerance	tolerance	NOUN
dpc-865	61	22	and	and	CCONJ
dpc-865	61	23	response	response	NOUN
dpc-865	61	24	.	.	PUNCT
dpc-865	62	1	several	several	ADJ
dpc-865	62	2	studies	study	NOUN
dpc-865	62	3	used	use	VERB
dpc-865	62	4	vincristine	vincristine	NOUN
dpc-865	62	5	monotherapy	monotherapy	NOUN
dpc-865	62	6	for	for	ADP
dpc-865	62	7	kmp	kmp	PROPN
dpc-865	62	8	with	with	ADP
dpc-865	62	9	good	good	ADJ
dpc-865	62	10	response	response	NOUN
dpc-865	62	11	rates	rate	NOUN
dpc-865	62	12	of	of	ADP
dpc-865	62	13	86	86	NUM
dpc-865	62	14	-	-	SYM
dpc-865	62	15	100	100	NUM
dpc-865	62	16	%	%	NOUN
dpc-865	63	1	[	[	X
dpc-865	63	2	13,14	13,14	NUM
dpc-865	63	3	]	]	PUNCT
dpc-865	63	4	.	.	PUNCT
dpc-865	64	1	in	in	ADP
dpc-865	64	2	observation	observation	NOUN
dpc-865	64	3	|	|	ADV
dpc-865	64	4	dermatol	dermatol	NOUN
dpc-865	64	5	pract	pract	PROPN
dpc-865	64	6	concept	concept	NOUN
dpc-865	64	7	2015;5(1):18	2015;5(1):18	PROPN
dpc-865	64	8	93	93	NUM
dpc-865	64	9	is	be	AUX
dpc-865	64	10	associated	associate	VERB
dpc-865	64	11	with	with	ADP
dpc-865	64	12	kaposiform	kaposiform	NOUN
dpc-865	64	13	hemangioendothelioma	hemangioendothelioma	NOUN
dpc-865	64	14	and	and	CCONJ
dpc-865	64	15	not	not	PART
dpc-865	64	16	with	with	ADP
dpc-865	64	17	common	common	ADJ
dpc-865	64	18	infantile	infantile	ADJ
dpc-865	64	19	hemangioma	hemangioma	NOUN
dpc-865	64	20	.	.	PUNCT
dpc-865	65	1	plast	plast	PROPN
dpc-865	65	2	reconstr	reconstr	PROPN
dpc-865	65	3	surg	surg	PROPN
dpc-865	65	4	1997;100:1377–86	1997;100:1377–86	NUM
dpc-865	65	5	.	.	PUNCT
dpc-865	66	1	5	5	NUM
dpc-865	66	2	.	.	PUNCT
dpc-865	66	3	enjolras	enjolras	PROPN
dpc-865	66	4	o	o	PROPN
dpc-865	66	5	,	,	PUNCT
dpc-865	66	6	wassef	wassef	PROPN
dpc-865	66	7	m	m	PROPN
dpc-865	66	8	,	,	PUNCT
dpc-865	66	9	mazoyer	mazoyer	NOUN
dpc-865	66	10	e	e	NOUN
dpc-865	66	11	,	,	PUNCT
dpc-865	66	12	et	et	PROPN
dpc-865	66	13	al	al	PROPN
dpc-865	66	14	.	.	PUNCT
dpc-865	67	1	infants	infant	NOUN
dpc-865	67	2	with	with	ADP
dpc-865	67	3	kasabachmerritt	kasabachmerritt	PROPN
dpc-865	67	4	syndrome	syndrome	PROPN
dpc-865	67	5	do	do	AUX
dpc-865	67	6	not	not	PART
dpc-865	67	7	have	have	VERB
dpc-865	67	8	“	"	PUNCT
dpc-865	67	9	true	true	ADJ
dpc-865	67	10	”	"	PUNCT
dpc-865	67	11	hemangiomas	hemangioma	NOUN
dpc-865	67	12	.	.	PUNCT
dpc-865	68	1	j	j	PROPN
dpc-865	68	2	pediatr	pediatr	PROPN
dpc-865	68	3	1997;130:631–40	1997;130:631–40	NUM
dpc-865	68	4	.	.	PUNCT
dpc-865	69	1	6	6	NUM
dpc-865	69	2	.	.	X
dpc-865	69	3	croteau	croteau	PROPN
dpc-865	69	4	se	se	PROPN
dpc-865	69	5	,	,	PUNCT
dpc-865	69	6	liang	liang	PROPN
dpc-865	69	7	mg	mg	PROPN
dpc-865	69	8	,	,	PUNCT
dpc-865	69	9	kozakewich	kozakewich	PROPN
dpc-865	69	10	hp	hp	PROPN
dpc-865	69	11	,	,	PUNCT
dpc-865	69	12	et	et	PROPN
dpc-865	69	13	al	al	PROPN
dpc-865	69	14	.	.	PUNCT
dpc-865	70	1	kaposiform	kaposiform	PROPN
dpc-865	70	2	hemangioendothelioma	hemangioendothelioma	PROPN
dpc-865	70	3	:	:	PUNCT
dpc-865	70	4	atypical	atypical	ADJ
dpc-865	70	5	features	feature	NOUN
dpc-865	70	6	and	and	CCONJ
dpc-865	70	7	risks	risk	NOUN
dpc-865	70	8	of	of	ADP
dpc-865	70	9	kasabachmerritt	kasabachmerritt	ADJ
dpc-865	70	10	phenomenon	phenomenon	NOUN
dpc-865	70	11	in	in	ADP
dpc-865	70	12	107	107	NUM
dpc-865	70	13	referrals	referral	NOUN
dpc-865	70	14	.	.	PUNCT
dpc-865	71	1	j	j	PROPN
dpc-865	71	2	pediatr	pediatr	PROPN
dpc-865	71	3	2013;162:142	2013;162:142	NUM
dpc-865	71	4	-	-	SYM
dpc-865	71	5	47	47	NUM
dpc-865	71	6	.	.	PUNCT
dpc-865	72	1	7	7	X
dpc-865	72	2	.	.	X
dpc-865	72	3	drolet	drolet	PROPN
dpc-865	72	4	ba	ba	PROPN
dpc-865	72	5	,	,	PUNCT
dpc-865	72	6	trenor	trenor	NOUN
dpc-865	72	7	cc	cc	PROPN
dpc-865	72	8	,	,	PUNCT
dpc-865	72	9	brandão	brandão	PROPN
dpc-865	72	10	lr	lr	PROPN
dpc-865	72	11	,	,	PUNCT
dpc-865	72	12	et	et	PROPN
dpc-865	72	13	al	al	PROPN
dpc-865	72	14	.	.	PROPN
dpc-865	73	1	consensusderived	consensusderive	VERB
dpc-865	73	2	practice	practice	NOUN
dpc-865	73	3	standards	standard	NOUN
dpc-865	73	4	plan	plan	NOUN
dpc-865	73	5	for	for	ADP
dpc-865	73	6	complicated	complicated	ADJ
dpc-865	73	7	kaposiform	kaposiform	NOUN
dpc-865	73	8	hemangioendothelioma	hemangioendothelioma	NOUN
dpc-865	73	9	.	.	PUNCT
dpc-865	74	1	j	j	PROPN
dpc-865	74	2	pediatr	pediatr	PROPN
dpc-865	74	3	2013;163(1):285	2013;163(1):285	NUM
dpc-865	74	4	-	-	SYM
dpc-865	74	5	91	91	NUM
dpc-865	74	6	.	.	NOUN
dpc-865	74	7	8	8	NUM
dpc-865	74	8	.	.	PUNCT
dpc-865	75	1	baselga	baselga	PROPN
dpc-865	75	2	e	e	NOUN
dpc-865	75	3	,	,	PUNCT
dpc-865	75	4	cordisco	cordisco	PROPN
dpc-865	75	5	mr	mr	PROPN
dpc-865	75	6	,	,	PUNCT
dpc-865	75	7	garzon	garzon	PROPN
dpc-865	75	8	m	m	PROPN
dpc-865	75	9	,	,	PUNCT
dpc-865	75	10	et	et	PROPN
dpc-865	75	11	al	al	PROPN
dpc-865	75	12	.	.	PUNCT
dpc-865	75	13	rapidly	rapidly	ADV
dpc-865	75	14	involuting	involute	VERB
dpc-865	75	15	congenital	congenital	ADJ
dpc-865	75	16	haemangioma	haemangioma	NOUN
dpc-865	75	17	associated	associate	VERB
dpc-865	75	18	with	with	ADP
dpc-865	75	19	transient	transient	ADJ
dpc-865	75	20	thrombocytopenia	thrombocytopenia	NOUN
dpc-865	75	21	and	and	CCONJ
dpc-865	75	22	coagulopathy	coagulopathy	ADJ
dpc-865	75	23	:	:	PUNCT
dpc-865	75	24	a	a	DET
dpc-865	75	25	case	case	NOUN
dpc-865	75	26	series	series	NOUN
dpc-865	75	27	.	.	PUNCT
dpc-865	76	1	br	br	PROPN
dpc-865	76	2	j	j	PROPN
dpc-865	76	3	dermatol	dermatol	NOUN
dpc-865	76	4	2008;158:1363	2008;158:1363	NUM
dpc-865	76	5	.	.	PUNCT
dpc-865	77	1	9	9	NUM
dpc-865	77	2	.	.	NUM
dpc-865	77	3	fahrtash	fahrtash	NOUN
dpc-865	77	4	f	f	NOUN
dpc-865	77	5	,	,	PUNCT
dpc-865	77	6	mccahon	mccahon	NOUN
dpc-865	77	7	e	e	NOUN
dpc-865	77	8	,	,	PUNCT
dpc-865	77	9	arbuckle	arbuckle	PROPN
dpc-865	77	10	s.	s.	PROPN
dpc-865	77	11	successful	successful	ADJ
dpc-865	77	12	treatment	treatment	NOUN
dpc-865	77	13	of	of	ADP
dpc-865	77	14	kaposiform	kaposiform	NOUN
dpc-865	77	15	hemangioendothelioma	hemangioendothelioma	NOUN
dpc-865	77	16	and	and	CCONJ
dpc-865	77	17	tufted	tufte	VERB
dpc-865	77	18	angioma	angioma	NOUN
dpc-865	77	19	with	with	ADP
dpc-865	77	20	vincristine	vincristine	NOUN
dpc-865	77	21	.	.	PUNCT
dpc-865	78	1	j	j	PROPN
dpc-865	78	2	pediatr	pediatr	PROPN
dpc-865	78	3	hematol	hematol	NOUN
dpc-865	78	4	oncol	oncol	ADJ
dpc-865	78	5	2010;32(6):506	2010;32(6):506	NUM
dpc-865	78	6	-	-	PUNCT
dpc-865	78	7	10	10	NUM
dpc-865	78	8	.	.	PUNCT
dpc-865	78	9	10	10	NUM
dpc-865	78	10	.	.	PUNCT
dpc-865	79	1	hall	hall	PROPN
dpc-865	79	2	gw	gw	PROPN
dpc-865	79	3	.	.	PUNCT
dpc-865	79	4	kasabach	kasabach	PROPN
dpc-865	79	5	-	-	PUNCT
dpc-865	79	6	merritt	merritt	PROPN
dpc-865	79	7	syndrome	syndrome	NOUN
dpc-865	79	8	:	:	PUNCT
dpc-865	79	9	pathogenesis	pathogenesis	NOUN
dpc-865	79	10	and	and	CCONJ
dpc-865	79	11	management	management	NOUN
dpc-865	79	12	.	.	PUNCT
dpc-865	80	1	br	br	X
dpc-865	80	2	j	j	PROPN
dpc-865	80	3	haematol	haematol	PROPN
dpc-865	80	4	2001	2001	NUM
dpc-865	80	5	mar;112(4):851	mar;112(4):851	NOUN
dpc-865	80	6	-	-	PUNCT
dpc-865	80	7	62	62	NUM
dpc-865	80	8	.	.	PUNCT
dpc-865	81	1	11	11	NUM
dpc-865	81	2	.	.	PUNCT
dpc-865	82	1	chiu	chiu	PROPN
dpc-865	82	2	ye	ye	PROPN
dpc-865	82	3	,	,	PUNCT
dpc-865	82	4	drolet	drolet	VERB
dpc-865	82	5	ba	ba	PROPN
dpc-865	82	6	,	,	PUNCT
dpc-865	82	7	blei	blei	PROPN
dpc-865	82	8	f	f	AUX
dpc-865	82	9	,	,	PUNCT
dpc-865	82	10	et	et	PROPN
dpc-865	82	11	al	al	PROPN
dpc-865	82	12	.	.	PUNCT
dpc-865	83	1	variable	variable	ADJ
dpc-865	83	2	response	response	NOUN
dpc-865	83	3	to	to	PART
dpc-865	83	4	propranolol	propranolol	VERB
dpc-865	83	5	treatment	treatment	NOUN
dpc-865	83	6	of	of	ADP
dpc-865	83	7	kaposiform	kaposiform	NOUN
dpc-865	83	8	hemangioendothelioma	hemangioendothelioma	NOUN
dpc-865	83	9	,	,	PUNCT
dpc-865	83	10	tufted	tufte	VERB
dpc-865	83	11	angioma	angioma	PROPN
dpc-865	83	12	,	,	PUNCT
dpc-865	83	13	and	and	CCONJ
dpc-865	83	14	kasabach	kasabach	NOUN
dpc-865	83	15	-	-	PUNCT
dpc-865	83	16	merritt	merritt	PROPN
dpc-865	83	17	phenomenon	phenomenon	NOUN
dpc-865	83	18	.	.	PUNCT
dpc-865	84	1	pediatr	pediatr	ADJ
dpc-865	84	2	blood	blood	NOUN
dpc-865	84	3	cancer	cancer	NOUN
dpc-865	84	4	2012;59(5):934	2012;59(5):934	PROPN
dpc-865	84	5	-	-	PUNCT
dpc-865	84	6	8	8	NUM
dpc-865	84	7	.	.	PUNCT
dpc-865	84	8	12	12	NUM
dpc-865	84	9	.	.	PUNCT
dpc-865	85	1	kai	kai	PROPN
dpc-865	85	2	l	l	PROPN
dpc-865	85	3	,	,	PUNCT
dpc-865	85	4	wang	wang	PROPN
dpc-865	85	5	z	z	PROPN
dpc-865	85	6	,	,	PUNCT
dpc-865	85	7	yao	yao	PROPN
dpc-865	85	8	w	w	PROPN
dpc-865	85	9	,	,	PUNCT
dpc-865	85	10	dong	dong	PROPN
dpc-865	85	11	k	k	PROPN
dpc-865	85	12	,	,	PUNCT
dpc-865	85	13	xiao	xiao	PROPN
dpc-865	85	14	x.	x.	PROPN
dpc-865	85	15	sirolimus	sirolimus	PROPN
dpc-865	85	16	,	,	PUNCT
dpc-865	85	17	a	a	DET
dpc-865	85	18	promising	promising	ADJ
dpc-865	85	19	treatment	treatment	NOUN
dpc-865	85	20	for	for	ADP
dpc-865	85	21	refractory	refractory	NOUN
dpc-865	85	22	kaposiform	kaposiform	NOUN
dpc-865	85	23	hemangioendothelioma	hemangioendothelioma	ADV
dpc-865	85	24	.	.	PUNCT
dpc-865	86	1	j	j	PROPN
dpc-865	86	2	cancer	cancer	NOUN
dpc-865	86	3	res	re	VERB
dpc-865	86	4	clin	clin	PROPN
dpc-865	86	5	oncol	oncol	PROPN
dpc-865	86	6	2014;140(3):471	2014;140(3):471	PROPN
dpc-865	86	7	-	-	SYM
dpc-865	86	8	76	76	NUM
dpc-865	86	9	.	.	NOUN
dpc-865	87	1	13	13	NUM
dpc-865	87	2	.	.	X
dpc-865	88	1	hermans	hermans	PROPN
dpc-865	88	2	dj	dj	PROPN
dpc-865	88	3	,	,	PUNCT
dpc-865	88	4	van	van	PROPN
dpc-865	88	5	beynum	beynum	PROPN
dpc-865	88	6	i	i	PROPN
dpc-865	88	7	m	m	PROPN
dpc-865	88	8	,	,	PUNCT
dpc-865	88	9	van	van	PROPN
dpc-865	88	10	der	der	PROPN
dpc-865	88	11	vijver	vijver	PROPN
dpc-865	88	12	rj	rj	PROPN
dpc-865	88	13	,	,	PUNCT
dpc-865	89	1	et	et	PROPN
dpc-865	89	2	al	al	PROPN
dpc-865	89	3	.	.	PUNCT
dpc-865	89	4	kaposiform	kaposiform	PROPN
dpc-865	89	5	hemangioendothelioma	hemangioendothelioma	PROPN
dpc-865	89	6	with	with	ADP
dpc-865	89	7	kasabach	kasabach	PROPN
dpc-865	89	8	-	-	PUNCT
dpc-865	89	9	merritt	merritt	PROPN
dpc-865	89	10	syndrome	syndrome	NOUN
dpc-865	89	11	:	:	PUNCT
dpc-865	89	12	a	a	DET
dpc-865	89	13	new	new	ADJ
dpc-865	89	14	indication	indication	NOUN
dpc-865	89	15	for	for	ADP
dpc-865	89	16	propranolol	propranolol	NOUN
dpc-865	89	17	treatment	treatment	NOUN
dpc-865	89	18	.	.	PUNCT
dpc-865	90	1	j	j	PROPN
dpc-865	90	2	pediatr	pediatr	PROPN
dpc-865	90	3	hematol	hematol	NOUN
dpc-865	90	4	oncol	oncol	ADJ
dpc-865	90	5	2011;33(4):171	2011;33(4):171	NUM
dpc-865	90	6	-	-	SYM
dpc-865	90	7	73	73	NUM
dpc-865	90	8	.	.	PUNCT
dpc-865	90	9	14	14	NUM
dpc-865	90	10	.	.	PUNCT
dpc-865	91	1	haisley	haisley	NOUN
dpc-865	91	2	-	-	PUNCT
dpc-865	91	3	royster	royster	NOUN
dpc-865	91	4	c	c	PROPN
dpc-865	91	5	,	,	PUNCT
dpc-865	91	6	enjolras	enjolras	PROPN
dpc-865	91	7	o	o	PROPN
dpc-865	91	8	,	,	PUNCT
dpc-865	91	9	et	et	PROPN
dpc-865	91	10	al	al	PROPN
dpc-865	91	11	.	.	PUNCT
dpc-865	91	12	kasabach	kasabach	PROPN
dpc-865	91	13	-	-	PUNCT
dpc-865	91	14	merritt	merritt	PROPN
dpc-865	91	15	phenomenon	phenomenon	NOUN
dpc-865	91	16	:	:	PUNCT
dpc-865	91	17	a	a	DET
dpc-865	91	18	retrospective	retrospective	ADJ
dpc-865	91	19	study	study	NOUN
dpc-865	91	20	of	of	ADP
dpc-865	91	21	treatment	treatment	NOUN
dpc-865	91	22	with	with	ADP
dpc-865	91	23	vincristine	vincristine	NOUN
dpc-865	91	24	.	.	PUNCT
dpc-865	92	1	j	j	PROPN
dpc-865	92	2	pediatr	pediatr	PROPN
dpc-865	92	3	hematol	hematol	NOUN
dpc-865	92	4	oncol	oncol	ADJ
dpc-865	92	5	2002;24(6):459	2002;24(6):459	NUM
dpc-865	92	6	-	-	SYM
dpc-865	92	7	62	62	NUM
dpc-865	92	8	.	.	PUNCT
dpc-865	92	9	15	15	NUM
dpc-865	92	10	.	.	PUNCT
dpc-865	93	1	monagle	monagle	PROPN
dpc-865	93	2	p	p	NOUN
dpc-865	93	3	,	,	PUNCT
dpc-865	93	4	chalmers	chalmer	NOUN
dpc-865	93	5	e	e	NOUN
dpc-865	93	6	,	,	PUNCT
dpc-865	93	7	chan	chan	PROPN
dpc-865	93	8	a	a	PROPN
dpc-865	93	9	,	,	PUNCT
dpc-865	93	10	et	et	PROPN
dpc-865	93	11	al	al	PROPN
dpc-865	93	12	.	.	PUNCT
dpc-865	93	13	antithrombotic	antithrombotic	ADJ
dpc-865	93	14	therapy	therapy	NOUN
dpc-865	93	15	in	in	ADP
dpc-865	93	16	neonates	neonate	NOUN
dpc-865	93	17	and	and	CCONJ
dpc-865	93	18	children	child	NOUN
dpc-865	93	19	:	:	PUNCT
dpc-865	93	20	american	american	PROPN
dpc-865	93	21	college	college	PROPN
dpc-865	93	22	of	of	ADP
dpc-865	93	23	chest	chest	NOUN
dpc-865	93	24	physicians	physician	NOUN
dpc-865	93	25	evidence	evidence	NOUN
dpc-865	93	26	-	-	PUNCT
dpc-865	93	27	based	base	VERB
dpc-865	93	28	clinical	clinical	ADJ
dpc-865	93	29	practice	practice	NOUN
dpc-865	93	30	guidelines	guideline	NOUN
dpc-865	93	31	(	(	PUNCT
dpc-865	93	32	8th	8th	ADJ
dpc-865	93	33	edition	edition	NOUN
dpc-865	93	34	)	)	PUNCT
dpc-865	93	35	.	.	PUNCT
dpc-865	94	1	chest	chest	NOUN
dpc-865	94	2	2008;133(6suppl):887s–968s	2008;133(6suppl):887s–968s	NUM
dpc-865	94	3	.	.	PUNCT
dpc-865	95	1	our	our	PRON
dpc-865	95	2	protocol	protocol	NOUN
dpc-865	95	3	,	,	PUNCT
dpc-865	95	4	antiaggregant	antiaggregant	ADJ
dpc-865	95	5	therapy	therapy	NOUN
dpc-865	95	6	(	(	PUNCT
dpc-865	95	7	aspirin	aspirin	NOUN
dpc-865	95	8	and	and	CCONJ
dpc-865	95	9	ticlopidine	ticlopidine	NOUN
dpc-865	95	10	)	)	PUNCT
dpc-865	95	11	in	in	ADP
dpc-865	95	12	combination	combination	NOUN
dpc-865	95	13	with	with	ADP
dpc-865	95	14	vincristine	vincristine	NOUN
dpc-865	95	15	is	be	AUX
dpc-865	95	16	used	use	VERB
dpc-865	95	17	as	as	ADP
dpc-865	95	18	primary	primary	ADJ
dpc-865	95	19	treatment	treatment	NOUN
dpc-865	95	20	for	for	ADP
dpc-865	95	21	kmp	kmp	PROPN
dpc-865	95	22	associated	associate	VERB
dpc-865	95	23	with	with	ADP
dpc-865	95	24	khe	khe	PROPN
dpc-865	95	25	(	(	PUNCT
dpc-865	95	26	vat	vat	NOUN
dpc-865	95	27	therapy	therapy	NOUN
dpc-865	95	28	)	)	PUNCT
dpc-865	95	29	.	.	PUNCT
dpc-865	96	1	this	this	DET
dpc-865	96	2	therapy	therapy	NOUN
dpc-865	96	3	is	be	AUX
dpc-865	96	4	continued	continue	VERB
dpc-865	96	5	until	until	SCONJ
dpc-865	96	6	normal	normal	ADJ
dpc-865	96	7	platelet	platelet	NOUN
dpc-865	96	8	count	count	NOUN
dpc-865	96	9	is	be	AUX
dpc-865	96	10	obtained	obtain	VERB
dpc-865	96	11	;	;	PUNCT
dpc-865	96	12	then	then	ADV
dpc-865	96	13	,	,	PUNCT
dpc-865	96	14	vincristine	vincristine	NOUN
dpc-865	96	15	is	be	AUX
dpc-865	96	16	generally	generally	ADV
dpc-865	96	17	discontinued	discontinue	VERB
dpc-865	96	18	and	and	CCONJ
dpc-865	96	19	antiaggregant	antiaggregant	ADJ
dpc-865	96	20	agents	agent	NOUN
dpc-865	96	21	are	be	AUX
dpc-865	96	22	continued	continue	VERB
dpc-865	96	23	,	,	PUNCT
dpc-865	96	24	although	although	SCONJ
dpc-865	96	25	the	the	DET
dpc-865	96	26	optimal	optimal	ADJ
dpc-865	96	27	duration	duration	NOUN
dpc-865	96	28	of	of	ADP
dpc-865	96	29	treatment	treatment	NOUN
dpc-865	96	30	has	have	AUX
dpc-865	96	31	not	not	PART
dpc-865	96	32	been	be	AUX
dpc-865	96	33	defined	define	VERB
dpc-865	96	34	.	.	PUNCT
dpc-865	97	1	the	the	DET
dpc-865	97	2	interest	interest	NOUN
dpc-865	97	3	of	of	ADP
dpc-865	97	4	the	the	DET
dpc-865	97	5	case	case	NOUN
dpc-865	97	6	lies	lie	VERB
dpc-865	97	7	in	in	ADP
dpc-865	97	8	the	the	DET
dpc-865	97	9	benefit	benefit	NOUN
dpc-865	97	10	of	of	ADP
dpc-865	97	11	the	the	DET
dpc-865	97	12	early	early	ADJ
dpc-865	97	13	management	management	NOUN
dpc-865	97	14	of	of	ADP
dpc-865	97	15	khe	khe	NOUN
dpc-865	97	16	complicated	complicate	VERB
dpc-865	97	17	by	by	ADP
dpc-865	97	18	kmp	kmp	PROPN
dpc-865	97	19	,	,	PUNCT
dpc-865	97	20	avoiding	avoid	VERB
dpc-865	97	21	the	the	DET
dpc-865	97	22	use	use	NOUN
dpc-865	97	23	of	of	ADP
dpc-865	97	24	corticosteroids	corticosteroid	NOUN
dpc-865	97	25	and	and	CCONJ
dpc-865	97	26	allowing	allow	VERB
dpc-865	97	27	the	the	DET
dpc-865	97	28	administration	administration	NOUN
dpc-865	97	29	of	of	ADP
dpc-865	97	30	fewer	few	ADJ
dpc-865	97	31	doses	dose	NOUN
dpc-865	97	32	of	of	ADP
dpc-865	97	33	vincristine	vincristine	NOUN
dpc-865	97	34	.	.	PUNCT
dpc-865	98	1	however	however	ADV
dpc-865	98	2	,	,	PUNCT
dpc-865	98	3	some	some	DET
dpc-865	98	4	discussion	discussion	NOUN
dpc-865	98	5	should	should	AUX
dpc-865	98	6	be	be	AUX
dpc-865	98	7	highlighted	highlight	VERB
dpc-865	98	8	;	;	PUNCT
dpc-865	98	9	early	early	ADJ
dpc-865	98	10	referral	referral	NOUN
dpc-865	98	11	of	of	ADP
dpc-865	98	12	patients	patient	NOUN
dpc-865	98	13	with	with	ADP
dpc-865	98	14	khe	khe	PROPN
dpc-865	98	15	to	to	ADP
dpc-865	98	16	centers	center	NOUN
dpc-865	98	17	with	with	ADP
dpc-865	98	18	expertise	expertise	NOUN
dpc-865	98	19	in	in	ADP
dpc-865	98	20	vascular	vascular	ADJ
dpc-865	98	21	anomalies	anomaly	NOUN
dpc-865	98	22	is	be	AUX
dpc-865	98	23	uncommon	uncommon	ADJ
dpc-865	98	24	and	and	CCONJ
dpc-865	98	25	diagnosis	diagnosis	NOUN
dpc-865	98	26	is	be	AUX
dpc-865	98	27	delayed	delay	VERB
dpc-865	98	28	in	in	ADP
dpc-865	98	29	most	most	ADJ
dpc-865	98	30	of	of	ADP
dpc-865	98	31	the	the	DET
dpc-865	98	32	cases	case	NOUN
dpc-865	98	33	.	.	PUNCT
dpc-865	99	1	also	also	ADV
dpc-865	99	2	,	,	PUNCT
dpc-865	99	3	there	there	PRON
dpc-865	99	4	are	be	VERB
dpc-865	99	5	potential	potential	ADJ
dpc-865	99	6	side	side	NOUN
dpc-865	99	7	effects	effect	NOUN
dpc-865	99	8	associated	associate	VERB
dpc-865	99	9	with	with	ADP
dpc-865	99	10	early	early	ADJ
dpc-865	99	11	treatment	treatment	NOUN
dpc-865	99	12	in	in	ADP
dpc-865	99	13	younger	young	ADJ
dpc-865	99	14	patients	patient	NOUN
dpc-865	99	15	.	.	PUNCT
dpc-865	100	1	vincristine	vincristine	PROPN
dpc-865	100	2	may	may	AUX
dpc-865	100	3	cause	cause	VERB
dpc-865	100	4	neuropathy	neuropathy	ADJ
dpc-865	100	5	and	and	CCONJ
dpc-865	100	6	antiaggregant	antiaggregant	ADJ
dpc-865	100	7	agents	agent	NOUN
dpc-865	100	8	may	may	AUX
dpc-865	100	9	cause	cause	VERB
dpc-865	100	10	bleeding	bleeding	NOUN
dpc-865	100	11	.	.	PUNCT
dpc-865	101	1	chronic	chronic	ADJ
dpc-865	101	2	use	use	NOUN
dpc-865	101	3	of	of	ADP
dpc-865	101	4	aspirin	aspirin	NOUN
dpc-865	101	5	has	have	AUX
dpc-865	101	6	been	be	AUX
dpc-865	101	7	associated	associate	VERB
dpc-865	101	8	with	with	ADP
dpc-865	101	9	the	the	DET
dpc-865	101	10	development	development	NOUN
dpc-865	101	11	of	of	ADP
dpc-865	101	12	reye	reye	PROPN
dpc-865	101	13	syndrome	syndrome	PROPN
dpc-865	101	14	,	,	PUNCT
dpc-865	101	15	but	but	CCONJ
dpc-865	101	16	the	the	DET
dpc-865	101	17	current	current	ADJ
dpc-865	101	18	recommendation	recommendation	NOUN
dpc-865	101	19	is	be	AUX
dpc-865	101	20	to	to	PART
dpc-865	101	21	discontinue	discontinue	VERB
dpc-865	101	22	the	the	DET
dpc-865	101	23	use	use	NOUN
dpc-865	101	24	of	of	ADP
dpc-865	101	25	aspirin	aspirin	NOUN
dpc-865	101	26	only	only	ADV
dpc-865	101	27	during	during	ADP
dpc-865	101	28	suspected	suspect	VERB
dpc-865	101	29	influenza	influenza	NOUN
dpc-865	101	30	or	or	CCONJ
dpc-865	101	31	varicella	varicella	NOUN
dpc-865	101	32	infections	infection	NOUN
dpc-865	101	33	[	[	X
dpc-865	101	34	15	15	NUM
dpc-865	101	35	]	]	PUNCT
dpc-865	101	36	.	.	PUNCT
dpc-865	102	1	references	reference	NOUN
dpc-865	102	2	1	1	NUM
dpc-865	102	3	.	.	PUNCT
dpc-865	103	1	zukerberg	zukerberg	PROPN
dpc-865	103	2	lr	lr	PROPN
dpc-865	103	3	,	,	PUNCT
dpc-865	103	4	nickoloff	nickoloff	NOUN
dpc-865	103	5	bj	bj	PROPN
dpc-865	103	6	,	,	PUNCT
dpc-865	103	7	weiss	weiss	PROPN
dpc-865	103	8	sw	sw	PROPN
dpc-865	103	9	.	.	PUNCT
dpc-865	103	10	kaposiform	kaposiform	PROPN
dpc-865	103	11	hemangioendothelioma	hemangioendothelioma	ADJ
dpc-865	103	12	of	of	ADP
dpc-865	103	13	infancy	infancy	NOUN
dpc-865	103	14	and	and	CCONJ
dpc-865	103	15	childhood	childhood	NOUN
dpc-865	103	16	.	.	PUNCT
dpc-865	104	1	an	an	DET
dpc-865	104	2	aggressive	aggressive	ADJ
dpc-865	104	3	neoplasm	neoplasm	NOUN
dpc-865	104	4	associated	associate	VERB
dpc-865	104	5	with	with	ADP
dpc-865	104	6	kasabach	kasabach	PROPN
dpc-865	104	7	-	-	PUNCT
dpc-865	104	8	merritt	merritt	PROPN
dpc-865	104	9	syndrome	syndrome	NOUN
dpc-865	104	10	and	and	CCONJ
dpc-865	104	11	lymphangiomatosis	lymphangiomatosis	NOUN
dpc-865	104	12	.	.	PUNCT
dpc-865	105	1	am	be	AUX
dpc-865	105	2	j	j	PROPN
dpc-865	105	3	surg	surg	NOUN
dpc-865	105	4	pathol	pathol	VERB
dpc-865	105	5	1993;17:321	1993;17:321	PROPN
dpc-865	105	6	-	-	SYM
dpc-865	105	7	28	28	NUM
dpc-865	105	8	.	.	PUNCT
dpc-865	106	1	2	2	X
dpc-865	106	2	.	.	X
dpc-865	106	3	sarkar	sarkar	PROPN
dpc-865	106	4	m	m	PROPN
dpc-865	106	5	,	,	PUNCT
dpc-865	106	6	mulliken	mulliken	PROPN
dpc-865	106	7	jb	jb	PROPN
dpc-865	106	8	,	,	PUNCT
dpc-865	106	9	kozakewich	kozakewich	PROPN
dpc-865	106	10	hp	hp	PROPN
dpc-865	106	11	,	,	PUNCT
dpc-865	106	12	robertson	robertson	PROPN
dpc-865	106	13	rl	rl	PROPN
dpc-865	106	14	,	,	PUNCT
dpc-865	106	15	burrows	burrow	VERB
dpc-865	106	16	pe	pe	PROPN
dpc-865	106	17	.	.	PUNCT
dpc-865	107	1	thrombocytopenic	thrombocytopenic	ADJ
dpc-865	107	2	coagulopathy	coagulopathy	ADJ
dpc-865	107	3	(	(	PUNCT
dpc-865	107	4	kasabach	kasabach	NOUN
dpc-865	107	5	-	-	PUNCT
dpc-865	107	6	merritt	merritt	PROPN
dpc-865	107	7	phenomenon	phenomenon	NOUN
dpc-865	107	8	)	)	PUNCT
dpc-865	107	9	is	be	AUX
dpc-865	107	10	associated	associate	VERB
dpc-865	107	11	with	with	ADP
dpc-865	107	12	kaposiform	kaposiform	NOUN
dpc-865	107	13	hemangioendothelioma	hemangioendothelioma	NOUN
dpc-865	107	14	and	and	CCONJ
dpc-865	107	15	not	not	PART
dpc-865	107	16	with	with	ADP
dpc-865	107	17	common	common	ADJ
dpc-865	107	18	infantile	infantile	ADJ
dpc-865	107	19	hemangioma	hemangioma	NOUN
dpc-865	107	20	.	.	PUNCT
dpc-865	108	1	plast	plast	PROPN
dpc-865	108	2	reconstr	reconstr	PROPN
dpc-865	108	3	surg	surg	PROPN
dpc-865	108	4	1997;100:1377	1997;100:1377	NUM
dpc-865	108	5	-	-	SYM
dpc-865	108	6	86	86	NUM
dpc-865	108	7	.	.	PUNCT
dpc-865	109	1	3	3	X
dpc-865	109	2	.	.	X
dpc-865	109	3	kelly	kelly	PROPN
dpc-865	109	4	m.	m.	PROPN
dpc-865	109	5	kasabach	kasabach	PROPN
dpc-865	109	6	-	-	PUNCT
dpc-865	109	7	merritt	merritt	PROPN
dpc-865	109	8	phenomenon	phenomenon	NOUN
dpc-865	109	9	.	.	PUNCT
dpc-865	110	1	pediatr	pediatr	PROPN
dpc-865	110	2	clin	clin	PROPN
dpc-865	110	3	north	north	PROPN
dpc-865	110	4	am	be	AUX
dpc-865	110	5	2010;57:1085–89	2010;57:1085–89	NUM
dpc-865	110	6	.	.	PUNCT
dpc-865	111	1	4	4	NUM
dpc-865	111	2	.	.	X
dpc-865	111	3	sarkar	sarkar	PROPN
dpc-865	111	4	m	m	PROPN
dpc-865	111	5	,	,	PUNCT
dpc-865	111	6	mulliken	mulliken	PROPN
dpc-865	111	7	jb	jb	PROPN
dpc-865	111	8	,	,	PUNCT
dpc-865	111	9	kozakewich	kozakewich	PROPN
dpc-865	111	10	hpw	hpw	PROPN
dpc-865	111	11	,	,	PUNCT
dpc-865	111	12	et	et	PROPN
dpc-865	111	13	al	al	PROPN
dpc-865	111	14	.	.	PROPN
dpc-865	111	15	thrombocytopenic	thrombocytopenic	PROPN
dpc-865	111	16	coagulopathy	coagulopathy	ADJ
dpc-865	111	17	(	(	PUNCT
dpc-865	111	18	kasabach	kasabach	NOUN
dpc-865	111	19	-	-	PUNCT
dpc-865	111	20	merritt	merritt	PROPN
dpc-865	111	21	129	129	NUM
dpc-865	111	22	phenomenon	phenomenon	NOUN
dpc-865	111	23	)	)	PUNCT